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Abstract
Novel Computational Methods for Bayesian Hierarchical Modeling in the Biomedical
Domain
by
Arya Alexander Pourzanjani
The recent growth in the availability of biomedical data promises to reshape health-
care by ushering in an era of personalized medicine where data can be used to diagnose
and treat patients with pinpoint accuracy. Truly realizing this goal requires building
statistical models that individually model patient variations such as age, sex, and ge-
netic makeup, which leads to a combinatorial growth in the number of parameters in a
model and noisy estimates. Fortunately, Bayesian hierarchical models, along with recent
computational advances, provide a solution to this issue. By naturally embedding the
hierarchical structure that many datasets exhibit into the model, these models allow for
separate estimates that capture population-level variation and simultaneously avoid noise
via regularization to a population mean.
In this thesis, we describe novel models and computational methods for Bayesian
hierarchical modeling of biomedical data. We begin by describing our contributions to
various areas of Bayesian modeling, along with the problems from our applied work that
motivated these contributions.
Specifically, we describe our disease progression model, which hierarchically models
patient disease trajectories. The model, which was motivated by our applied work on
Alzheimer’s Disease, utilizes I-splines to capture the characteristic monotonic shape of
dementia disease trajectories, along with Dirichlet distributions over the coefficients of
these I-splines to hierarchically model these trajectories. Next we describe our work on
ix
using the Givens Representation of orthogonal matrices to infer models with orthogonal
matrix parameters, such as factor models, in a general Bayesian framework. We describe
the innovations in our method along with our motivating hierarchical example based on
the analysis of protein biomarkers of coagulopathic trauma patients. Next, we describe
a mechanistic model of coagulopathy that relates clotting assay data to protein concen-
trations, effectively providing a fast and convenient way for clinicians to understand key
protein markers involved in clotting.
Next we transition specifically to Hamiltonian Monte Carlo (HMC) and elucidate
the connection between multiscale posterior distributions and the efficiency of HMC.
We describe the issue of numerical stability inside HMC and present our implicit HMC
algorithm for efficiently sampling non-Gaussian posterior distributions.
Lastly, we provide a summary of our contributions along with ideas for future work.
x
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Chapter 1
Introduction
1.1 Motivation
Bayesian modeling, and Bayesian hierarchical modeling in particular, is an immensely
powerful tool for the modeling and analysis of modern datasets, both large and small.
In short, hierarchical models allow the modeler to embed their knowledge of natural
hierarchies within data to effectively capture the heterogeneity of the data, while si-
multaneously regularizing unstable estimates to a common, group mean [1]. In many
datasets, a hierarchical structure that can be utilized is often readily apparent. As an
example, within a dataset containing biomarker data for individual hospital patients,
we may naturally group the observations first by the hospital at which it was collected.
Within each hospital we may group our observations by the type of injury the patient
sustained. Within each injury group we may group observations based on relevant indi-
vidual characteristics such as age or sex (Figure 1.1). While we expect variation within
each group, we simultaneously expect that patients within a group can be informative of
one another. For example, we may expect that two patients of similar age who sustained
similar injuries and are being treated at the same hospital may exhibit unique biomarker
1
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Figure 1.1: Natural hierarchies are readily apparent in many practical datasets, such
as biomedical data which may be grouped by hospital, then injury type, and finally
by patient type.
trajectories, however it would not be unreasonable for these observations to be informa-
tive of one another. Hierarchical modeling allows us to naturally encode this intuition
within our models.
At the time of this writing, an explosion is occurring in the amount of data available in
the medical domain. The price of genome sequencing has surpassed the pace of Moore’s
law, providing a wealth of individualized data to study every disease imaginable [2]. Large
datasets with hierarchical structures, like the aforementioned examples, are becoming
more and more available, and with them comes the promise of “personalized medicine”,
which many expect to immensely improve health outcomes and lives in the upcoming
years [3, 4, 5]. The premise of personalized medicine is that with more data we will be
able to capture individual patient characteristics, which will in turn allow us to provide
2
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more targeted therapy. However, within this lies a contradiction, the solution of which
hierarchical modeling provides. In particular, to truly personalize our decisions we must
account for every unique characteristic of a patient e.g. their age, sex, genome, type
and extent of injury etc. Unfortunately, once we group patients by all these relevant
characteristics to conduct statistical inference, our once large dataset has been reduced
to many small datasets which individually are difficult to learn from with such small
sample sizes. Hierarchical modeling solves this challenge, by simultaneously grouping
patients and treating them separately to a degree that the data can support.
At the same time that medical data has become more and more available, advances
in the field of Bayesian computation have allowed for the modeling and inference of
larger and larger models, including hierarchical models which were previously intractable
to infer. In particular, the advent of the Hamiltonian Monte Carlo (HMC) sampling
method of Duane et al. [6] and its subsequent introduction to the statistics community
by Neal [7] has opened the flood gates for practical inference of high-dimensional models
by practitioners. Unlike the Metropolis method [8] which was in wide use before HMC,
HMC can scale to larger dimensions at an almost linear rate [9]. More recently, the No-
U-Turn Sample (NUTS) extension of HMC by Hoffman and Gelman [10] and advances in
automatic differentiation have led to practical software packages such as Stan that make
the power of HMC available to wide audiences [11].
This work lies at the intersection of these recent advances in medical data availability
and Bayesian computation, where I have conducted my research for the past few years.
In particular, I describe novel models and computational techniques for inference that
I have developed over the years in pursuit of my goal to better understand biology and
medicine via data analysis.
3
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1.2 Organization
In Chapters 2, 3, 4, and 5, I describe our advances in the respective areas of disease
progression, factor modeling, and mechanistic modeling along with motivating examples
from our applied work. In Chapter 6, I go over the relationship between Bayesian pos-
teriors and the numerical solution of differential equations and I describe our Implicit
HMC method for inference of multiscale posterior distributions. I close with a summary
of our contributions along with future directions in Chapter 7.
4
Chapter 2
Disease Progression Models
Disease progression modeling is a rapidly growing area of data science that seeks to use
patient data to quantify and forecast the severity of a disease [12, 13, 14]. This chapter
summarizes our work titled “Diagnosing Alzheimer’s the Bayesian Way” published in
the Proceedings of StanCon, Asilomar (2018) [15]. We describe linear models of disease
progression. Next we describe our nonlinear disease progression model that utilizes I-
splines and hierarchical Dirichlet priors. Lastly, we describe the specific application of
our model to Alzheimer’s Disease.
2.1 Linear Models of Disease Progression
Several existing models of disease progression, particularly in Alzheimer’s Disease,
utilize monotonic functions to capture the continual worsening of biomarkers. Jedynak
et al. posit that the deterioration of individual biomarkers is tied to a single latent state
for each patient that increases monotonically over time [16]. This latent variable can thus
be used as a disease progression score, representing how far in the disease an individual
has progressed (Figure 2.1).
5
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Figure 2.1: Diagram of a disease progression model with a single latent state repre-
senting disease severity.
While the model was originally presented in a frequentist least-squares framework, if
we let yij(t) denote the jth biomarker for the ith patient at age t, the original model can
be translated to the probabilistic generative model
si(t) = αit+ βi (2.1)
yij(t) ∼ N (f(si(t) | aj, bj, cj, dj), σj), (2.2)
where σj represents the measurement variability for the jth biomarker and f(·|aj, bj, cj, dj)
represents a biomarker-specific 4-parameter sigmoid-curve for the jth biomarker
f(s | aj, bj, cj, dj) = aj
1 + e−bjs−cj
+ dj. (2.3)
The parameters cj and bj are of particular importance because they indicate when
a biomarker starts deteriorating and how fast it deteriorates once it does. Figures 2.2
and 2.3 show posterior distributions of these parameters on the Bayesian version of this
model fit to real dementia data using the priors
6
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Figure 2.2: Posterior distribution of bj parameters of the linear disease progression
model fit to Alzheimer’s data.
γ ∼ HalfNormal(0, 10) (2.4)
αi ∼ HalfNormal(0, γ). (2.5)
The values of the bj and cj parameters illustrate the relative speed of progression of the
four biomarkers in this dementia disease progression model. The form of the degradation
of the biomarkers takes the form of a logistic (or S-curve) because in practice, biomarkers
often seem to get worse slowly at first, then rapidly, and eventually hit a saturation
point. We note that one of the biomarkers has to have fixed values for b and c, to ensure
identifiability of the parameters.
In this model, si(t) is a monotonically increasing transformation of age that represents
a continuous disease progression score for the ith individual. The individual specific
parameters αi and βi determine the rate of progression and relative onset of disease
7
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Figure 2.3: Posterior distribution of cj parameters of the linear disease progression
model fit to Alzheimer’s data.
Figure 2.4: Posterior distribution of patient disease trajectories from the linear disease
progression model fit to Alzheimer’s data.
respectively for the ith individual. To ensure the progression variable si(t) is monotonic
in time, αi is constrained to be positive. Figure 2.4 shows posterior draws of what these
curves typically look like, while Figure 2.5, shows associated biomarker trajectories.
We note that while each patient has a unique set of parameters that describe their per-
sonal latent disease progression score, the parameters that describe individual biomarker
evolution in the sigmoid function are constant across the population. This implies that
the degradation of the biomarkers occurs in the same relative order and relative rate in
all patients, an assumption that would have to be properly verified by examining the
8
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Figure 2.5: Posterior distribution of patient biomarker trajectories from the linear
disease progression model fit to Alzheimer’s data.
relative rates of deterioration in individuals.
2.2 Nonlinear Modeling of Disease Progression Us-
ing I-Splines
While a linear fit can do a reasonable job of capturing each individual’s progression
of biomarkers over time, it leaves much to be desired. The model assumes that the rate
of progression of the disease is constant, i.e. that patients’ disease status continuously
progress at the same rate. In reality, it can often be the case that there are plateaus of
progression, such as in vascular dementia, where progression can slow down then later
pick back up, due either to endogenous or exogenous circumstances. To more flexibly
represent disease progression curves requires a way to flexibly model monotonic functions
of age. Lorenzi et al. [17] use a monotonic Gaussian Process to model how each biomarker
deteriorates over time in the population, and use ordinary Gaussian Processes for each
9
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individual, to describe random deviations from this general progression at the individual
level. To achieve monotonicity in their Gaussian Processes, they use the method proposed
in [18], and fit their model using Expectation Propagation (EP)[17]. To achieve a full
Bayesian implementation that can be fit using standard inference methods, we instead
turn to I-Splines.
2.2.1 I-Splines
I-Splines are a flexible and adjustable set of monotone basis functions used to model
monotonic functions [19]. By taking a linear combination of these functions, and con-
straining the coefficients to be positive, one can flexibly model a wide class of monotone
functions. Similarly, one can model increasing functions with a range from 0 to 1, by
taking a linear combination of the I-Splines where the coefficients are constrained to sum
to one.
To our knowledge, the only other known method for flexibly modeling monotone
functions are monotone Gaussian Processes [18], which were used by [17]. This method
relies on constraining the Gaussian Process to have a positive derivative at a set number
of points, which then usually forces the function to monotone. While attractive, the
method may not return true monotone functions and it is not clear how to select the
points where the derivative should be positive.
Given a domain, and a set of nodes t1, · · · , tD on that domain, the I-Spline basis
functions are obtained by integrating the piece-wise-defined M-Splines, themselves a set
of spline functions defined on the same domain using the same nodes. M-Splines are
defined recursively. The order one M-Spline functions are piece-wise constant functions.
The ith M-Spline of order one is defined as
10
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Figure 2.6: Various M-Spline bases.
Mi1(x) :=

1
(ti+1−ti) , ti ≤ x < ti+1
0, otherwise
(2.6)
while the ith M-Spline of order k is defined recursively as
Mik(x) :=
(
k
k − 1
)
(x− ti)Mi,k−1(x) + (ti+k − x)Mi+1,k−1(x)
ti+k − ti . (2.7)
One can show that the M-Spline basis functions each integrate to one over the specified
domain and are positive. Figure 2.6 shows the M-Spline basis functions for orders k =
1, 2, 3, 4 using custom code written to generate M-Splines in R.
Because M-Splines integrate to one over the specified domain and are positive, their
integral will be a set of functions that monotonically increase from 0 to 1 over the domain.
Since the M-Splines are piece-wise polynomials, this integral is easy to compute. Figure
11
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Figure 2.7: I-spline basis.
2.7 illustrates an I-spline basis over the domain [−20, 20].
Positive linear combinations of I-Splines will be monotone, while convex linear com-
binations will be monotone and range from 0 to 1. We use this idea to expand the linear
latent progression model to a more flexible latent progression using I-Splines. Specif-
ically, we replace the latent disease progression function, si(t), with a positive linear
combination of I-Splines, rather than with a linear function.
2.3 Application to Alzheimer’s Disease and Demen-
tia
The progression of Alzheimer’s Disease (AD) is characterized by the gradual deteri-
oration of biomarkers and eventual loss of basic memory and decision-making functions,
which makes the I-spline model ideal. Using these biomarker values and other tests to
estimate how far an individual has progressed in the disease is valuable in diagnosis as
well as in assessing the efficacy of interventions. Additionally, prediction of how the in-
dividual will continue to progress is critical in decision making. While it is known that
AD only gets worse over time, it is believed that patients with the disease progress at
different rates and at different stages of their lives. There is no standard path of progres-
12
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sion for people with the disease, which makes estimation of disease severity and future
progression difficult. In addition to estimating these paths for an individual given their
measurements, it is of clinical and biological significance to be able to understand the
order in which certain biomarkers begin to deteriorate, and what their distribution might
look like for various stages of the disease.
Currently, staging of AD is accomplished by the thorough review of a patient by a
panel of expert doctors. While this diagnosis serves as a gold-standard, the diagnosis
process is cumbersome, prone to subjectivity, and typically only includes three discrete
levels, which does not represent the continuously progressing nature of AD. These three
stages are, in order of severity: Normal (NL), Mild Cognitive Impairment (MCI), and
Dementia.
2.3.1 Data
For our analysis we used a pre-cleaned table of biomarker data from the publicly
available Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset. The dataset con-
tains various biomarker measurements for 1,737 patients, as well as their age at the time
of measurement. The biomarkers measured include the following:
• ABETA: Concentration of the amyloid-beta protein in cerebrospinal fluid (CSF),
measured in pg/ml. In healthy individuals this harmful protein is actively cleared
from the brain in to the CSF. In individuals with AD, the amyloid-beta protein
concentrates in the brain to form harmful plaques. Low levels in the CSF indicate
the protein is not being cleared from the brain, and is thus an indication of AD.
• HIPPO: Volume of the individual’s hippocampal brain region as measured by MRI
and normalized to their baseline brain volume. In AD the hippocampus is known
13
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Figure 2.8: MRI imaging of a human brain.
to shrink in size as the disease progresses. Volume is typically estimated using
software applied to images like Figure 2.8.
• MMSE: Mini-Mental State Examination (MMSE) test. A 30-point questionnaire
administered by psychologists to assess working memory and brain function in an
individual. Patients with AD show lower scores in MMSE, but unfortunately low-
ered MMSE scores typically only show once the disease has progressed significantly.
• TAU: Concentration of tau protein in the CSF, measured in pg/ml. Tau is a protein
that shows up as a byproduct of dead neurons. High tau in the CSF indicates an
abundance of dying neurons in the brain.
Population histograms of these biomarkers during the three stages of the disease
reveal a monotonic pattern in the four biomarkers we are considering (Figure 2.9). For
example, ABETA appears to be a biomodal distribution where the lower mode becomes
more common as the disease worsens. The distribution of HIPPO appears to shift to
14
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Figure 2.9: Histograms of patient biomarker data over the three stages of Alzheimer’s
Disease.
the left with increased worsening of AD. These observations lead us to believe that these
biomarkers can be modeled as coming from a single continuous latent variable that we
can interpret as being a disease progression score.
Figure 2.10 shows biomarker trajectories for ten different patients over time.
2.3.2 Model
In addition to replacing the linear disease progression curves with I-splines, we let the
measurement variability of the ABETA measurements be different for each individual,
and place a hierarchical prior over these parameters. The biomarker plots suggest that
the random variation in these measurements may differ in magnitude from person to
person.
2.3.3 Results
Once fit using Stan, posterior draws of individual disease progression curves imme-
15
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Figure 2.10: Longitudinal trajectories of biomarker data for ten separate patients.
diately reveal possible non-linearities in disease progression (Figure 2.11). While some
patients, such as patient 4, still maintain approximately linear disease progression, oth-
ers such as patient 5 or 9 display slow initial progression then a sharp worsening in the
disease. Others, such as patient 7, seem to worsen then have a flattened prior where
progression is slow, followed by another quickly progressing epoch. These more flexible
disease progression curves also manifest in seemingly more accurate biomarker progres-
sion curves (Figure 2.12), leaving us with an overall more trustworthy and robust model.
16
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Figure 2.11: Posterior draws of nonlinear trajectories from the I-spline model.
Figure 2.12: Posterior draws of nonlinear biomarker trajectories from the I-spline model.
17
Chapter 3
Factor Models and other Models
with Orthogonal Matrix Parameters
In this chapter we present our work titled “General Bayesian Inference over the Stiefel
Manifold via the Givens Transform” [20] where we introduce an approach based on the
Givens representation that allows for a routine, reliable, and flexible way to infer Bayesian
models with orthogonal matrix parameters. This class of models most notably includes
models from multivariate statistics such as factor models and probabilistic principal com-
ponent analysis (PPCA). Our approach overcomes several of the practical barriers to
using the Givens representation in a general Bayesian inference framework. In partic-
ular, we show how to inexpensively compute the change-of-measure term necessary for
transformations of random variables. We also show how to overcome specific topological
pathologies that arise when representing circular random variables in an unconstrained
space. In addition, we discuss how the alternative parameterization can be used to de-
fine new distributions over orthogonal matrices as well as to constrain parameter space
to eliminate superfluous posterior modes in models such as PPCA. While previous ap-
proaches to this inference problem involved specialized updates to the orthogonal matrix
18
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parameters, our approach lets us represent these constrained parameters in an uncon-
strained form. Unlike previous approaches, this allows for the inference of models with
orthogonal matrix parameters using any modern inference algorithm, including those
available in modern Bayesian modeling frameworks such as Stan, Edward, or PyMC3.
We illustrate with examples how our approach can be used in practice in Stan to infer
models with orthogonal matrix parameters, and we compare to existing methods.
3.1 Introduction
Statistical models parameterized in terms of orthogonal matrices are ubiquitous, par-
ticularly in the treatment of multivariate data. This class of models includes certain
multivariate time series models [21], factor models [22], and a swath of recently devel-
oped probabilistic dimensionality reduction models such as Probabilistic PCA (PPCA),
Exponential Family PPCA (BXPCA), mixture of PPCA [23], and Canonical Correlation
Analysis (CCA) [24, Chapt. 12.5]. These sorts of models have not only enjoyed extensive
use in fields such as psychology [25], but are also gaining traction in diverse applications
including biology [26], finance [27], materials science [28], and robotics [29].
Despite their ubiquity, their remains no quick, routine, and flexible options for fitting
models with orthogonal matrix parameters. Existing methods for inferring these models
are either insufficiently general or too complicated to implement and tune in isolation.
Modern probabilistic programming frameworks, such as Stan, Edward, and PyMC3 [30,
31, 32], try to abstract their users away from the details of inference and implementation,
but none offer support for orthogonal matrix parameters. The reason is that rather than
using a specialized inference algorithm for orthogonal matrices, which existing approaches
do, these software frameworks typically handle constrained parameters such as orthogonal
matrices by transforming them to an unconstrained space [30, 33]. For example, if a
19
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model contains a parameter σ > 0 that is constrained to be positive, these frameworks
typically take the log of this parameter and conduct inference over σ˜ = log σ, which is
unconstrained.
An unconstrained parameterization of orthogonal matrices would allow for general
Bayesian inference in any software framework without having to change its inner-workings,
but because of the complexities in dealing with the space of orthogonal matrices, oth-
erwise known as the Stiefel manifold, several challenges remain in the way of this ap-
proach. While many parameterizations of orthogonal matrices exist [34, 35], only smooth
representations, such as the Givens representation, can be practically considered, as in-
ference methods such as Hamiltonian Monte Carlo (HMC) typically require continuous
and differentiable likelihoods. Furthermore, any such transformation of a random vari-
able typically requires computing a change-of-measure adjustment term that is often
unknown or expensive to compute. A further complication is that the Stiefel manifold
has a fundamentally different topology than Euclidean space, which can lead to biased
inference if particular care is not taken in implementation. Lastly, while not strictly
necessary, any representation would ideally have an intuitive interpretation that would
allow practitioners to work with and even define useful distributions in terms of the new
representation.
We introduce a general approach to the posterior inference of statistical models with
orthogonal matrix parameters based on the Givens representation of orthogonal matrices.
We address several practical implementation issues such as computation of the change-
of-measure adjustment, as well as proper handling of transformed coordinates to ensure
unbiased samples. Our approach enables the application of any general inference algo-
rithm to models containing orthogonal matrix parameters, allowing inference of these
models by any commonly available inference algorithm such as HMC [7], the No-U-Turn
Sampler (NUTS) [10], Automatic Differentiation Variational Inference (ADVI) [33] or
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Black Box Variational Inference [36]. Unlike existing approaches, our approach is easy to
implement and does not require any specialized inference algorithms or modifications to
existing algorithms or software. This allows users to rapidly build and prototype com-
plex probabilistic models with orthogonal matrix parameters in any common software
framework such as Stan, Edward, or PyMC3 without the worry of messy implementation
details.
In Section 3.2 we discuss existing methods for Bayesian inference over the Stiefel man-
ifold and the difficulty in implementing these methods in a general Bayesian inference
framework. In Section 3.3 we describe the Givens representation by first introducing
the Givens reduction algorithm and then connecting it to a geometric perspective of
the Stiefel manifold, providing an approachable intuition to the transform. We go on
to describe practical solutions for using the Givens representation in a general Bayesian
inference setting in Section 3.4. In Section 3.5 we illustrate with statistical examples
the use of the Givens representation and how it compares to existing methods in prac-
tice. Lastly, we conclude with a brief discussion in Section 3.6 where we summarize our
contributions.
3.2 Related Work
Hoff et al. [37] introduces a Gibbs sampling approach to update unknown orthogonal
matrix parameters from a collection of known conditional distributions. Unfortunately,
this requires that the conditional distribution of the orthogonal matrix parameter given
other model parameters belongs to a known parametric distribution that is easy to sam-
ple. In practice, this limits the approach to a specific class of models.
More general HMC methods have been devised, but their use of specialized update rules
makes them difficult to implement and tune in practice. In particular, these methods
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infer orthogonal matrix parameters by using different HMC update rules for constrained
and unconstrained parameters. This separation of constrained and unconstrained pa-
rameters requires additional book-keeping to know which update rules to use on which
parameter. Unfortunately, many probabilistic programming languages do not keep track
of this as they treat parameters agnostically by transforming to an unconstrained space.
The specialization of these methods to HMC also makes them difficult to generalize to
other inference algorithms based on VI or optimization which an unconstrained param-
eterization approach would have no trouble with.
Specifically, Brubaker et al. [38] proposed a modified HMC, which uses a different
update rule for constrained parameters based on the symplectic SHAKE integrator [39].
For unconstrained parameters, the method uses a standard Leapfrog update rule. For
constrained parameters, the method first takes a Leapfrog step which usually moves the
parameter to a value that does not obey constraints. The method then uses Newton’s
method to “project” the parameter value back down to the manifold where the desired
constraints are satisfied.
Byrne and Girolami [40] as well as Holbrook et al. [41] also utilize a separate HMC
update rule to deal with constrained parameters. Specifically, they utilize analytic results
and the matrix exponential to update the parameters in such a way that guarantees
constraints are still satisfied in the embedded matrix coordinates. More precisely, they
use the fact that analytic solutions for the geodesic equations on the Stiefel manifold
in the embedded coordinates are known. This gives rise to their Embedded Manifold
HMC (EMHMC) algorithm. Like the method of [38], the use of separate update rules in
EMHMC makes the algorithm difficult to implement in more general settings.
22
Factor Models and other Models with Orthogonal Matrix Parameters Chapter 3
3.3 The Givens Representation of Orthogonal Ma-
trices
We motivate and introduce the Givens representation by first describing the related
Givens reduction algorithm of numerical analysis and then tying this to the geometric
aspects of the Stiefel manifold.
3.3.1 Givens Rotations and Reductions
Given any n× p matrix, A, the Givens reduction algorithm is a numerical algorithm
for finding the QR-factorization of A, i.e. an n × p orthogonal matrix Q and an upper-
triangular p × p matrix R such that A = QR. The algorithm works by successively
applying a series of Givens rotations so as to “zero-out” elements of A below the diagonal.
These Givens rotations are simply n × n matrices, Rij(θij), that take the form of an
identity matrix except for the (i, i) and (j, j) positions which are replaced by cos θij and
the (i, j) and (j, i) positions which are replaced by − sin θij and sin θij respectively.
When applied to a vector, Rij(θij) has the effect of rotating the vector counter-
clockwise in the (i, j)-plane, while leaving other elements fixed. Intuitively, its inverse,
R−1ij (θij), has the same effect, but clockwise. Thus one can “zero-out” the jth element,
uj, of a vector u, by first using the arctan function to find the angle θij formed in the
(i, j)-plane by ui and uj, and then multiplying by the matrix R
−1
ij (θij) (Figure 3.1, inset).
In the Givens reduction algorithm, these rotation matrices are applied one-by-one to
A in this way to eliminate all elements below the diagonal. First, all elements in the first
column below the first row are eliminated by successively applying the rotation matrices
R−112 (θ12), R
−1
13 (θ13), · · · , R−11n (θ1n) (Figure 3.2). Because multiplication by Rij(θij) only
affects elements i and j of a vector, once the jth element is zeroed out, the subsequent
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Figure 3.1: (Inset) Givens rotations can be used to rotate a vector so as to eliminate
its component in a certain direction. (Main Figure) A p-frame on the Stiefel manifold
can be visualized as a set of rigidly connected orthogonal basis vectors, u1 and u2,
shown here in black. One can move about the Stiefel manifold and describe any
p-frame by simultaneously applying rotations matrices of a prescribed angle to these
basis vectors. Applying the rotation matrix R12(θ12) corresponds to rotating the two
basis vectors toegher in the (1,2)-plane, which by our convention is the (x, y)-plane.
Similarly, simultaneously apply R13(θ13) corresponds to a rotation of the 2-frame in
the (1, 3) or (x, z)-plane, while R23(θ23) corresponds to rotating u2 about u1.
rotations, R−113 (θ13), · · · , R−11n (θ1n), will leave the initial changes unaffected. Similarly,
once the first column of A is zeroed out below the first element, the subsequent rotations,
which do not involve the first element will leave the column unaffected. The rotations
R−123 (θ23), · · · , R−12n (θ2n) can thus be applied to zero out the second column, while leaving
the first column unaffected. This results in the upper triangular matrix
Figure 3.2: The Givens reduction eliminates lower diagonal elements of an n × p
matrix one column at a time. Because each rotation, Rij(θij), only affects rows i and
j, previously zeroed out elements do not change.
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R∗ := R−1pn (θpn) · · ·R−1p,p+1(θp,p+1) · · ·R−12n (θ2n) · · ·R−123 (θ23) · · ·R−11n (θ1n) · · ·R−112 (θ12)︸ ︷︷ ︸
Q−1∗
A.
(3.1)
Crucially, the product of rotations, which we call Q−1∗ , is orthogonal since it is simply
the product of rotation matrices which are themselves orthogonal. Thus its inverse can
be applied to both sides of Equation 3.1 to obtain
Q∗R∗ = A. (3.2)
The familiar QR form can be obtained by setting Q equal to the first p columns of Q∗
and setting R equal to the first p rows of R∗. The Givens reduction is summarized in
Algorithm 1.
Input: A
Result: Q,R
Q−1∗ = I R∗ = A
for i in 1:p do
for j in (i+1):n do
θij = arctan(Y [j, i]/Y [i, i])
Q−1∗ = R
−1
ij (θij)Q
−1
∗
R∗ = R−1ij (θij)R∗
end
end
return Q∗[, 1 : p], R∗[1 : p, 1 : p]
Algorithm 1: Psuedo-code for the Givens reduction algorithm for obtaining the QR
factorization of a matrix A.
3.3.2 The Geometry of Orthogonal Matrices
The Stiefel manifold, Vp,n, consists of p-frames: ordered sets of p n-dimensional unit-
length vectors, where p ≤ n. p-frames naturally correspond to n× p orthogonal matrices
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which can be used to define the Stiefel manifold succinctly as
Vp,n := {Y ∈ Rn×p : Y TY = I}. (3.3)
Geometrically, an element of the Stiefel manifold can be pictured as a set of orthog-
onal, unit-length vectors that are rigidly connected to one another. A simple case is
V1,3, which consists of a single vector, u1, on the unit sphere. This single vector can
be represented by two polar coordinates that we naturally think of as longitude and
latitude, but can also be thought of simply as subsequent rotations of the standard
basis vector e1 := (1, 0, 0)
T in the (x, y) and (x, z) planes, which we refer to as the
(1, 2) and (1, 3) planes for generality. In mathematical terms, u1 can be represented as
u1 = R12(θ12)R13(θ13)e1 (Figure 3.1).
Continuing without geometric interpretation, V2,3 can be pictured as a vector in V1,3
that has a second orthogonal vector, u2, that is rigidly attached to it as it moves about
the unit sphere. Because this second vector is constrained to be orthogonal to the first,
its position can be described by a single rotation about the first vector. Thus elements
of V2,3 can be represented by three angles: two angles, θ12 and θ13, that represent how
much to rotate the first vector, and a third angle, θ23 that controls how much the second
vector is rotated about the first (Figure 3.1). Mathematically this can be represented as
the 3× 2 orthogonal matrix R12(θ12)R13(θ13)R23(θ23)(e1, e2).
Although elements of the Stiefel manifold can be represented by n× p matrices, their
inherent dimension is less than np because of the constraints that the matrices must
satisfy. The first column must satisfy a single constraint: the unit-length constraint.
The second column must satisfy two constraints: not only must it be unit length, but
it must also be orthogonal to the first column. The third column must additionally be
orthogonal to the second column, giving it a total of three constraints. Continuing in
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this way reveals the inherent dimensionality of the Stiefel manifold to be
d := np− 1− 2− · · · p = np− p(p+ 1)
2
. (3.4)
3.3.3 Obtaining the Givens Representation
The Givens reduction applied to an orthogonal matrix gives rise to a representation
of the Stiefel manifold that generalizes the intuitive geometric interpretation described
above. When applied to an n× p orthogonal matrix Y , the Givens reduction yields
R−1pn (θpn) · · ·R−1p,p+1(θp,p+1) · · ·R−12n (θ2n) · · ·R−123 (θ23) · · ·R−11n (θ1n) · · ·R−112 (θ12)Y = In,p
(3.5)
where Ip,n is defined to be the first p columns of the n × n identity matrix, i.e. the
matrix consisting of the first p standard basis vectors e1, · · · , ep. The first n−1 rotations
transform the first column into e1, since it zeros out all elements below the first and the
orthogonal rotations do not affect the length of the vector which by hypothesis is unit
length. Similarly, the next n − 2 rotations will leave the length of the second column
and its orthogonality to the first column intact because again, the rotation matrices are
orthogonal. Because the second column must be zero below its second element it must
be e2. Continuing in this way explains the relationship in Equation 3.5.
Because Y was taken to be an arbitrary orthogonal matrix, then it is clear from
Equation 3.5 that any orthogonal matrix Y can be factored as
Y = R12(θ12) · · ·R1n(θ1n) · · ·R23(θ23) · · ·R2n(θ2n) · · ·Rp,p+1(θp,p+1) · · ·Rpn(θpn)In,p.
(3.6)
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Defining Θ := (θ12 · · · θ1n · · · θ23 · · · θ2nθp,p+1 · · · θpn) we can consider any orthogonal
matrix as a function, Y (Θ), of these angles, effectively parameterizing the Stiefel man-
ifold and yielding the Givens representation. The Givens representation is a smooth
representation with respect to the angles Θ [35], and lines up with our geometric insight
discussed in the previous subsection.
3.4 The Givens Representation for Bayesian Infer-
ence of Orthogonal Matrix Parameters
Practical use of the Givens representation in a general Bayesian inference framework
involves solving several practical challenges. In addition to the standard change of mea-
sure term required in any transformation of a random variable, care must be taken to
address certain pathological cases of the Givens representation that occur due to the dif-
ferent topologies of the Stiefel manifold and Euclidean space. We further describe these
challenges and explain how we overcome them in practice. We also briefly remark on
how the Givens representation can be leveraged in practice to solve issues with identifia-
bility, and define new and useful distributions over the Stiefel manifold. We conclude the
section by describing how the computation of the Givens representation scales in theory,
particularly in comparison to EMHMC.
3.4.1 Transformation of Measure Under the Givens Represen-
tation
As is usual in any transformation of random variables, care must be taken to include a
Jacobian determinant term in the transformed density to account for a change of measure
under the transformation. For a posterior density over orthogonal matrices that takes
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the form pY (Y ), the proper density over the transformed random variable, Θ(Y ), takes
the form pΘ(θ) = pY (Y (Θ))|JY (Θ)(Θ)| [42]. Intuitively, this extra Jacobian determinant
term accounts for how probability measures are distorted by the transformation (Figure
3.3). Unfortunately, the Givens representation, Y (Θ), is a map from a space of dimension
d := np − p(p + 1)/2 to a space of dimension np. Hence the determinant is non-square
and thus undefined.
uniform sampling
angle space
non-uniform sampling
on Stiefel Manifold
Figure 3.3: Uniform sampling in the Givens representation coordinates does not neces-
sarily lead to uniform sampling over the Stiefel manifold without the proper measure
adjustment term. Under the mapping, regions near the pole are shrunk to regions
on the sphere with little area, as opposed to regions near to the equator which the
transform maps to much larger areas on the sphere. Intuitively, the change-of-measure
term quantifies this proportion of shrinkage in area.
To compute the change of measure term analogous to the Jacobian determinant, one
must appeal to the algebra of differential forms. We denote the product of n×n rotation
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matrices in the Givens representation by G, i.e.
G := R12(θ12) · · ·R1n(θ1n) · · ·R23(θ23) · · ·Rpn(θpn) · · ·Rp,p+1(θp,p+1) · · ·Rpn(θpn), (3.7)
and its jth column by Gj. The paper [43] shows that the proper measure form for a
signed surface element of Vp,n is the differential form
p∧
i=1
n∧
j=i+1
GTj dYi. (3.8)
Letting JYi(Θ)(Θ) be the Jacobian of the ith column of Y with respect to the angle
coordinates of the Givens representation, this differential form can be written in the
coordinates of the Givens representation as
p∧
i=1
n∧
j=i+1
GTj JYi(Θ)(Θ)dΘ. (3.9)
Because this is a wedge product of d d-dimensional elements, Equation 3.9 can be con-
veniently written as the determinant of the d× d matrix

GT2:nJY1(Θ)(Θ)
GT3:nJY2(Θ)(Θ)
...
GTp:nJYp(Θ)(Θ)

, (3.10)
where Gk:l denote columns k through l of G. As we show in the Appendix, this term can
be analytically simplified to the following simple product whose absolute value serves as
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our measure adjustment term:
p∏
i=1
n∏
j=i+1
cosj−i−1 θij. (3.11)
3.4.2 Implementation of Angle Coordinates
When using the Givens representation for general Bayesian inference in practice, care
must be taken to properly account for pathologies that arise from mapping the Stiefel
manifold to Euclidean space. We let θ12, θ23, · · · θp,p+1 range from −pi to pi and we refer
to these specific coordinates as the latidinal coordinates, to evoke the analogy for the
simple spherical case. Similarly, we let the remaining coordinates range from −pi/2
to pi/2 and we refer to these coordinates as longitudinal coordinates. This choice of
intervals defines a coordinate chart from Euclidean space to the Stiefel manifold, i.e. a
mapping between the two spaces. As is inevitable with any coordinate chart between
differing topological spaces, there is a subset of the Stiefel manifold of measure zero
that the Givens representation will be unable to represent because the topologies of the
Stiefel manifold and Euclidean space differ. For V1,3 this corresponds to a sliver of the
sphere (Figure 3.4). Furthermore, the coordinate chart will contain singularities where
the adjustment term (Equation 3.11) becomes zero, possibly biasing any distributional
calculations. On the sphere, this corresponds to areas on the unconstrained space being
mapped to smaller and smaller areas near the pole (Figure 3.4). We further discuss these
pathologies and introduce techniques to overcome them in practice.
As is routinely done in practice, a logistic transform can be used to map the interval
[−pi, pi] to the unconstrained interval (−∞,∞). Unfortunately, this leaves regions of
parameter space that should otherwise be connected, disconnected by the aforementioned
set of measure zero. In practice, this can lead to biased sampling where regions of
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Figure 3.4: The angular coordinates chart has an infinitesimal sliver of measure zero
that lies between θ12 = −pi and θ12 = pi that separates the two parts of the sphere in
the Givens representation. The grid over the sphere reveals how the Givens represen-
tation maps areas that are the same size in the Θ coordinates to smaller and smaller
regions on the sphere the closer they are to the poles.
parameter space with equal mass are not visited for equal amounts of time if the posterior
is not sufficiently concentrated (Figure 3.5, upper).
To overcome this, we create for each longitudinal angle, θ, a pair of coordinates x
and y then set θ = arctan(y/x). Introducing this auxilary dimension connects otherwise
separate regions of parameter space. Furthermore, we let r =
√
x2 + y2 ∼ N (1, 0.1).
This helps in practice to avoid regions of parameter space where arctan is ill-defined,
while leaving the marginal distribution of θ untouched (Figure 3.5, lower).
For the latitudinal angles, we can use the standard technique of constraining the
parameters over an interval, then using the logistic transform. However, to avoid singu-
larities in the measure adjustment term, we set the interval to the slightly smaller interval
[−pi/2+, pi/2−] rather than the full interval [−pi/2, pi/2]. Here  is a small value (on the
order of 10−5 in our experiments) that effectively blocks off a small portion of parameter
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Figure 3.5: (Upper) When posterior mass is not sufficiently bounded away from the
edges of the interval, regions of posterior mass that are separated by massless regions
may arise. Because these relatively massless regions are difficult for a sampler to
traverse, biased sampling can often occur, as the sampler is only able to visit one
mode of the posterior distribution. (Lower) By introducing an auxiliary coordinate,
one can effecitvely replicate the topology of a circle, effectively “wrapping” the two
ends of the interval, leading to unbiased sampling.
space surrounding the singularities of the change of measure term. In the spherical case,
this is equivalent to a small patch on either pole that is blocked off. In practice, blocking
off this small region avoid issues such as divergences that occur in HMC in such regions
of high curvature, while not meaningfully affecting the results of posterior inference.
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3.4.3 Coordinate Charts and Identifiability
For certain applications such as PPCA, it may be desirable to further limit parameter
space to avoid symmetries that lead to identifiability issues in the posterior. In the
Givens representation coordinates this is simply a matter of constraining the range of
the longitudinal angles to the interval [−pi/2, pi/2] (Figure 3.6). Unfortunately, as in the
case of the full interval, this can lead to biased sampling due to regions of low mass
separating regions of high mass in parameter space. However, this issue can be resolved
by carefully connecting these regions via a simple mirroring technique which we describe
next.
Figure 3.6: PPCA seeks to find the best lower dimensional p-frame to describe a
high-dimensional set of points. For n = 2 and p = 1, this corresponds to the vector
that most closely describes a set of two-dimensional points that lie close to flat line.
Since a p-frame and its negative can describe the data equally well, a multi-modal
posterior over the Stiefel manifold results. By limiting the longitudinal angle to lie in
the interval [−pi/2, pi/2] the sampler does not consider this redundant mode.
We can allow the original longitudinal and latitudinal coordinates, θlon and θlat to
freely roam the Stiefel manifold using the aforementioned approach then define the new
transformed parameters θ∗lon and θ
∗
lat to essentially be mirrored versions of these original
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coordinates. Specifically, we can define
θ∗lon =

θlon, |θlon| ≤ pi2
−pi
2
+ (θlon − pi2 ), θlon > pi2
pi
2
+ (θlon +
pi
2
), θlon < −pi2
(3.12)
and
θ∗lat =

θlat, |θlon| ≤ pi2
−θlat, |θlon| > pi2 .
(3.13)
These transformed coordinates essentially mirror and reflect the original coordinates
so that once the hemisphere is crossed, the path taken continues on the opposite side of the
Stiefel manifold, where there would naturally be an area of high posterior mass (Figure
3.7). In fact, one can check that the PPCA likelihood (Equation 3.16) is continuous
with respect to these new coordinates, allowing for efficient sampling even when there is
appreciable posterior mass near the edge of the hemisphere.
3.4.4 New Distributions Using the Givens Representation
Rather than placing priors over standard orthogonal matrix coordinates, Y , one can
place priors over the coordinates of the Givens representation Θ. In practice this leads to
new classes of possible distributions. [44] utilize sparsity promoting priors over the coor-
dinates of the Givens representation to produce a distribution over the Stiefel manifold
that favors sparse matrices. They apply this distribution to the estimation of normal
mixture classification probabilities. [45] make use of a different parameterization of or-
thogonal matrices to define a distribution over orthogonal matrices.
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Figure 3.7: Occasionally, the direction that best describes a high-dimensional dataset
in PPCA (black line) is near the boundary of the longitudinal coordinate (thick black
border). In this case, its negative will have an appreciable probability mass near it and
the same density. Because of this continuity in the density, these areas of parameter
space can be smoothly connected. Specifically, once the border is crossed (blue path)
the coordinates now describe a point on the opposite end of the Stiefel manifold (green
path).
3.4.5 Computational Scaling of the Givens Representation
The primary computational cost in using the Givens representation is the series of d
n × n matrix multiplications applied to In,p in Equation 3.6. Fortunately, unlike dense
matrix multiplication, applying a Givens rotation to an n × p matrix involves only two
vector additions of size p (Algorithm 2). Thus, since d scales on the order of np, compu-
tation of the Givens representation in aggregate scales as O(np2).
In comparison, EMHMC involves an orthogonalization of an n×p matrix which scales
as O(np2) and a matrix exponential computation that scales as O(p3) [40]. In practice,
we find that EMHMC scales better when p is much smaller than n, whereas the Givens
representation scales better when p is large and closer to n. We present benchmarks in
the following section.
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Input: θ
Result: Y
Y = In,p; idx = d
for i in p:1 do
for j in n:(i+1) do
Yi = cos(θidx)Y [i, ]− sin(θidx)Y [j, ]
Yj = sin(θidx)Y [i, ] + cos(θidx)Y [j, ]
Y [i, ] = Yi
Y [j, ] = Yj
idx = idx− 1
log density += (j − i− 1) log cos θidx
end
end
return Y
Algorithm 2: Psuedo-code for obtaining the orthogonal matrix Y from the Givens
Representation as well as appropriately adjusting the log of the posterior density.
3.5 Results and Examples
We demonstrate the use of the Givens representation and compare it with EMHMC
for three common statistical examples from the literature. All Givens representation
experiments were conducted in Stan using Stan’s automatic warm-up and tuning options.
For all Stan experiments, we ensured that there were no divergences during post-warmup
sampling and that all Rˆ were 1.01 or below. All timing experiments were conducted on
a 2016 Macbook Pro.
3.5.1 Uniform Sampling on the Stiefel Manifold
We sample uniformly from the Stiefel manifold of various sizes to assess the practical
scalability of the Givens representation. We compare its sampling efficiency and Rˆ values
to EMHMC on 500 post-warmup samples from each method (Table 3.1).
As mentioned in Section 3.4.1, to uniformly sample the Stiefel manifold in the Givens
representation, the change of measure term, Equation 3.11, must be computed as part
of the likelihood. Meanwhile, uniform sampling over the Stiefel manifold is achieved
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EMHMC Givens
p n Rˆ neff Rˆ neff
1 10 1.00 231 1.00 496
1 100 1.00 317 1.00 488
1 1000 1.00 238 1.00 487
10 10 1.00 408 1.00 390
10 100 1.00 473 1.00 487
10 1000 1.00 454 1.00 488
100 100 1.00 484 1.00 479
Table 3.1: Rˆ and neff values averaged over all elements of the matrix parameter Y .
in EMHMC simply using a constant likelihood because the method uses the original
matrix coordinates. However, as mentioned in Section 3.4.5, this comes at the cost
of an expensive HMC update to ensure that the updated parameter still satisfies the
constraints.. In practice, we find that EMHMC scales better as n is increased, although
the approach using the Givens representation in Stan remains competitive (Figure 3.8).
Figure 3.8: For small values of n the Givens representation approach in Stan produces
more effective samplers per second while for larger values the EMHMC scales better
since the primary cost of the matrix exponential remains constant.
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3.5.2 Probabilistic PCA (PPCA)
Factor Analysis (FA) and Probabilistic PCA (PPCA) [46] posit a probabilistic gen-
erative model where high-dimensional data is determined by a linear function of some
low-dimensional latent state [24, Chapt. 12]. Geometrically, for a three-dimensional set
of points forming a flat pancake-like cloud, PCA can be thought of as finding the best
2-frame that aligns with this cloud (Figure 3.9). Formally, PPCA posits the follow-
ing generative process for how a sequence of high-dimensional data vectors xi ∈ Rn,
i = 1, · · · , N arise from some low dimensional latent representations zi ∈ Rp (p < n):
zi ∼ Np(0, I)
xi|zi,W,Λ, σ2 ∼ Nn(WΛzi, σ2I). (3.14)
To ensure identifiability, W is constrained to be an orthogonal n×p matrix, while Λ is
a diagonal matrix with positive, ordered elements. Because xi is a linear transformation
of a multivariate Gaussian, its distribution is also multivariate Gaussian with mean zero
and covariance C := Wλ2W T + σ2 [24]. Letting Σˆ := (1/N)
∑N
i=1 xix
T
i denote the
empirical covariance matrix, this gives us the simplified PPCA likelihood
p(x1, · · · ,xN |W,σ2) = −N
2
ln |C| − 1
2
N∑
i=1
xTi C
−1xi (3.15)
= −N
2
ln |C| − N
2
tr(C−1Σˆ). (3.16)
Traditional PCA corresponds to the closed-form maximum likelihood estimator for
W in the limit as σ2 → 0, providing no measure of uncertainty for this point-estimate.
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Figure 3.9: PCA finds a single orthogonal matrix in the Stiefel Manifold that is closest,
in terms of average squared distance, to the set of points. This point estimate can of-
ten mislead us from the true subspace, which in this case is the horizontal (x, y)-plane
which was used to generate the noisy data. The data shown here is within the three-
-dimensional space parameterized by x, y, and z. Alternatively, in Probabilistic PCA
(PPCA) a posterior distribution is used to estimate the approximating subspace and
also to quantify the uncertainty of the result.
Furthermore, for more elaborate models, the analytical form of the maximum-likelihood
estimator is rarely known.
We used the Givens representation to infer this model using simulated data. Specifically,
we generated a three-dimensional dataset that lies on a two-dimensional plane with N =
15 observations according to the above generative process. The data is plotted in Figure
3.9). We chose diag(Λ) = diag(2, 1), σ2 = 1, and W to be I3,2, which in the Givens
representation corresponds to θ12 = θ13 = θ23 = 0 i.e. the horizontal plane. We point
out how this horizontal plane differs from the slanted plane obtained from the classical
PCA maximum likelihood estimate (Figure 3.9). In this case, the advantage of the full
posterior estimate that the Bayesian framework affords is clear. Posterior samples of θ13,
which if we recall from Figure 3.1 is the Givens representation angle that controls the
upwards tilt of the plane, reveal a wide posterior which cautions us against the spurious
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maximum likelihood estimate of θˆ13 = −0.15 (Figure 3.10, right). Note also that by
naturally constraining the set of angles considered as in Section 3.4.3, the superfluous
modes that EMHMC visits are avoided. Likewise, posterior distributions of Λ are more
informative than point estimates for quantifying the inherent dimensionality of the data
(Figure 3.10, left).
Figure 3.10: PPCA inference for three-dimensional synthetic data. (Left) Poste-
rior draws of the Λ parameter are more informative in dimensionality selection than
point-estimates. The posterior distributions for Λ1 and Λ2 (dark grey, and grey) con-
tain almost no mass near zero, suggesting that the data probably contains significant
variation in those directions. Meanwhile, the posterior Λ3 (orange) has it posterior
mode at zero, suggesting there is a high probability that this parameter is close to
zero, which the point estimate by itself neglects to convey. (Right) By limiting the
angles of rotation in the Givens Transform, we can further avoid unidentifiability in
our problem and eliminate multi-modal posteriors that show up in other methods such
as EMHMC.
3.5.3 The Network Eigenmodel
To illustrate the Givens representation on a more elaborate model with orthogonal
matrix parameters, we used it to infer the network eigenmodel of [37] on real data and
compared it to EMHMC. The same model was inferred using EMHMC by [40]. The data,
which was originally described in [47] and freely available in the R package eigenmodel,
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consists of a symmetric 230× 230 graph matrix, Y , which encodes whether the proteins
in a protein network of size n = 230 interact with one another.
The probability of a connection between all combinations of proteins can be de-
scribed by the lower-triangular portion of a symmetric matrix of probabilities, however
the network eigenmodel uses a much lower dimensional representation to represent this
connectivity matrix. Specifically, given an orthogonal matrix U , a diagonal matrix Λ,
and a scalar c, then letting Φ(·) represent the probit link function, the model is described
as follows:
c ∼ N (0, 102) (3.17)
Λi ∼ N (0, n), ∀i (3.18)
Yij ∼ Bernoulli
(
Φ([UΛUT ]ij + c)
)
, ∀i > j. (3.19)
The Stan implementation using the Givens representation took approximately 300
seconds to collect 1000 samples, 500 of which were warmup. In contrast, EMHMC took
812 seconds to run the same 1000 samples using the hyperparameter values specified in
[40]. Figure 3.11 compares traceplots for c,Λ, and the elements of the top row U for the
500 post warmup samples from each sampler. As mentioned in [40] the non-ordering of
the Λ parameters results in a multimodality in the posterior whereby values of Λ can be
“flipped”. Computed Rˆ and neff for these parameters are shown in Table 3.2.
3.6 Discussion
We have introduced a systematic approach to incorporating the Givens representation
into a general Bayesian inference framework for the purpose of inferring general Bayesian
42
Factor Models and other Models with Orthogonal Matrix Parameters Chapter 3
Figure 3.11: Traceplots of samples from the Givens representation implementation in
Stan and EMHMC reveal the multimodality in the elements of Λ. For brevity, only
the top three elements of U are shown.
models with orthogonal matrix parameters. Our approach overcomes practical barriers to
using the Givens representation in such a setting, including having to efficiently compute
the measure adjustment term and dealing with singularities caused by differences in
topology. Furthermore, we also provided an intuitive explanation behind the Givens
representation that is accessible to statisticians and followed with practical examples for
which we provide code. We expect our approach can be used quite widely in practice by
a variety of practitioners.
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EMHMC Givens
Parameter Rˆ neff Rˆ neff
c 1.00 22 1.00 496
Λ1 1.00 19 1.00 500
Λ2 1.00 23 1.00 500
Λ3 1.10 18 1.00 500
U [1, 1] 1.01 500 1.00 500
U [2, 1] 1.00 500 1.00 500
U [3, 1] 1.02 500 1.00 500
Table 3.2: Rˆ and neff values for the parameters in the network eigenmodel. For
brevity, only three of the matrix parameters are shown.
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Chapter 4
Hierarchical Factor Analysis in
Coagulopathy
In this chapter, we present our work titled “Understanding Coagulopathy using Multi-
view Data in the Presence of Sub-Cohorts: A Hierarchical Subspace Approach” [48]
published in the proceedings of the 2018 Machine Learning for Healthcare Conference in
the Journal of Machine Learning Research (JMLR). Death from trauma is most often the
result of uncontrollable bleeding as a result of Acute Traumatic Coagulopathy (ATC), a
disease that manifests itself differently in different sub-cohorts of trauma patients. Un-
derstanding the mechanisms of ATC and how existing patient tests can inform us about
these mechanisms is key to treating the disease. We introduce a hierarchical Canonical
Correlation Analysis (CCA) model that captures a lower dimensional representation of
the coagulation system based on blood protein and other tests. The hierarchial nature
of the model is ideal in the setting where multiple sub-cohorts are present, but statistical
strength can reasonably be borrowed from similar groups. We illustrate how the model
may be useful in understanding and treating ATC.
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4.1 Introduction
Trauma is the leading cause of death between the ages of 1 and 44 [49]. Major trauma
often induces a coagulopathic state known as Acute Traumatic Coagulopathy (ATC) that
manifests in increased bleeding and resultant mortality [50]. Despite the coagulation
cascade being a well-studied field in biochemistry, the causes and mechanisms behind
ATC are still uncertain [51].
One of the primary difficulties in treating ATC is information scarcity. During trauma
care, the state of the coagulation system is often assessed by thromboelastography (TEG).
This assay allows for quick assessment of the patient’s clotting potential using the vis-
coelastic properties of the patient’s blood such as time to clot formation, clotting rate,
clot strength, and rate of clot lysis. Unfortunately, TEG does not provide much insight
on specific clotting factor levels which can highlight the abnormalities causing ATC. As-
says that test for plasma protein levels can take much longer than TEG or may not be
available. Thus, treatment decisions must be made with limited information. If we can
use historical data and other patient data to ascertain the relationship between plasma
protein levels and TEG, decision making can be improved at the point of care.
While some protein data has been collected and analyzed [52], a consensus mechanism
for ATC remains to be found. One possible reason for this is that there may not a single
mechanism behind ATC. Currently, ATC is characterized primarily by clot times, but
assuming a single mechanism can obfuscate the more likely heterogeneous nature of the
disease that has been alluded to previously in the literature [52]. The coagulation system
is a complex network of reactions with many positive and negative feedback mechanisms
[53]. Because of this, there are many possible mechanisms that can cause the system to
fail. Distilling these mechanisms into a small collection of easily-interpretable variables
would go a long way towards better understanding of ATC. This could potentially enable
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recognition of phenotypes using limited information such as TEG results, in order to
inform decision making in practice.
Further complicating the issue is the inherent heterogeneity in patients and injury
types. Coagulopathy is not relegated to any particular form of trauma or injury mech-
anism, e.g. car accidents or gunshot wounds. A-priori, we would expect that patients
with different types of injury might have different coagulopathic phenotypes and cannot
be grouped together in an analysis.
We propose a probabilistic graphical model that extends canonical correlation analysis
(CCA) to distill the complex network of interactions in trauma-induced coagulopathy
into a small set of easy-to-understand variables. The model extends CCA in such a
way as to allow different sub-cohorts (based on injury mechanism) to be represented by
different latent variables, i.e. subspaces. At the same time, the model is able to “borrow”
information between similar sub-cohorts when data in a particular sub-cohort is sparse.
This latter feature is accomplished by placing a hierarchical prior over the orthornormal
matrices of weights used in CCA, via the recently introduced Givens representation. To
our knowledge this is the first application of hierarchical modeling (in the Bayesian sense)
to CCA, PCA, or any kind of model with orthornormal matrix parameters, as this task
was previously intractable for even small problems without a change of representation
that the Givens transform provides.
We show how, when applied to blood protein assays and TEG measurements, our
model can find different low-dimensional descriptions of the coagulation system for dif-
ferent sub-cohorts of injured patients, and how the model can share information across
sub-cohorts, via hierarchical modeling. We then illustrate how the shared subspace prop-
erties of CCA may be used in a clinical setting to phenotype patients and guide treatment
using TEG measurements (i.e. without expensive and time-consuming protein assays).
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4.2 Cohort
Our dataset consists of whole blood collected from 174 patients upon arrival to the
emergency department of a Level I trauma center between 2005 to 2015 as part of an
ongoing study [54].
4.2.1 Cohort and Sub-Cohort Selection
To remove any bias arising from age and differing injury severity, we selected patients
below the age of 45 and with an injury severity score greater than or equal to 25, a
common threshold used to mark severe injury in past studies. We examined patients suf-
fering from gun shot wounds (GSW), motor vehicle collisions (MVC), stab wounds (SW)
and assault, representing a diverse set of possible injury mechanisms. These divisions are
also representative of groups with larger sample sizes (GSW) and smaller sample sizes
(assault) to illustrate the inferential power of our hierarchical model. A summary of our
sub-cohorts is given in Table B.1.
4.2.2 Feature Choices
For each patient, we examined the TEG and blood protein assays. These consist
of values of R, K, MA, and Ly30 for TEG and FactorII, FactorX, Protein C, D-Dimer,
Fibrinogen, and Platelets for blood protein. The values are collectively referred to as
xteg and xprot for the remainder of this work. Table B.2 in the Appendix summarizes the
number of missing entries for these values amongst the 174 total patients. We describe
in the methods section how we account for these missing values.
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4.3 Methods
We start with a description of how we handle missing values in our analysis, and give
a short introduction into Canonical Correlation Analysis. Next, we provide a description
of how we conduct full Bayesian posterior inference over the orthornormal matrix param-
eters present in CCA using the Givens transform and Stan [30]. Finally we describe our
novel extension to CCA that takes into account the heterogeneity between sub-cohorts
present in our dataset via Bayesian hierarchical modeling.
4.3.1 Missing Values
We use multiple imputation as described in [55] to conduct inference while properly
accounting for the extra uncertainty that arises from missing data. Specifically, we draw
five imputed datasets, conduct Hamiltonian Monte Carlo (HMC) inference in Stan sepa-
rately on these imputed datasets, and then combine all posterior samples (after sampling
is complete) into a single pool of samples. In this way our posterior samples represent
a mixture of posteriors under various imputation possibilities. For actual imputation we
use a nonparametric random imputation method based on CART and described in [55].
4.3.2 CCA and Probabilistic CCA (PCCA)
Canonical correlation analysis (CCA) is an extension of PCA used to extract cross-
covariance information about a pair of related datasets, or views, that are tied to a
common set of samples [24]. The classical formulation of CCA finds a pair of linear
projections that maximize the shared variance between the two views. Inspecting the
obtained projections allows one to observe the level of commonality across views.
The probabilistic formulation of CCA (PCCA), [56], posits a generative process for the
same task. Formally, if we have two sets of different data types, or views, xprot ∈ RDprot
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and xteg ∈ RDteg , we can define for each view a set of orthonormal loading matrices
W and B and corresponding diagonal matrices, Λ and Γ, that describe the variance
explained by each latent dimension. Then for each sample i ∈ (1, ...N), we can define
three lower-dimensional latent variables: one for each view, z
(i)
prot ∈ RLprot and z(i)teg ∈ RLteg ,
and a shared latent variable that connects both views: z
(i)
s ∈ RLs . We define z(i) :=
(z
(i)
prot, z
(i)
teg, z
(i)
s ). A single data point for sample i is generated according to the following
specification:
z(i) ∼ N (z(i)prot|0, ILprot)N (z(i)s |0, ILs)N (z(i)teg|0, ILteg) (4.1)
x
(i)
prot ∼ N (x(i)prot|BxΓxz(i)prot +WprotΛprotz(i)s + µprot, σ2protIDprot) (4.2)
x
(i)
teg ∼ N (x(i)teg|ByΓtegz(i)teg +WtegΛtegz(i)s + µteg, σ2tegIDteg). (4.3)
The maximum likelihood estimate (MLE) for this model converges to the solution of
classical CCA up to an invariant rotation of the axis, as shown in [56]. The intuition
behind this generative process is that by introducing a shared latent variable zs, the
learned W matrices capture information that is shared between the two views, while the
B matrices capture information that is not contained in the other view. A graphical
model of this process is shown in Figure 4.1.
Automatic Dimensionality Selection We note that the diagonal matrices Λ and
Γ serve as importance weights, in the sense that they describe the weight given to each
latent dimension in predicting the higher dimensional data. When these weights are close
to zero, they indicate that a latent dimension has no predictive relationship to the data.
Thus, examining these weights can yield insight into the inherent dimensionality of the
data. Specifically, using full posterior draws of Λ and Γ allows us to make probabilistic
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Figure 4.1: Graphical Model of a Non-Hierarchical CCA for our dataset. We attach
various zero-centered Cauchy priors on the angles of the orthonormal matrices under
the Givens parameterization to induce sparsity in our solutions.
statements about the inherent dimensionality of our data, e.g. if posterior draws show
that a weight is below some value, then with high probability we can conclude that the
latent dimension is unnecessary. We use this type of analysis for selection of the latent
dimension in our results. We place Cauchy priors over importance weights as well as
matrix coefficients to induce sparsity, as described in the Appendix.
4.3.3 Hierarchical Modeling and Hierarchical CCA
Treating dissimilar patients, such as patients with different types of injuries, as a
single homogeneous group will lead to statistical bias in any inference. On the other
hand, a full model where separate parameters are allocated and estimated for each of a
multitude of sub-cohorts can lead to large models with many parameters that usually
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result in high uncertainty estimates in the fully Bayesian case, and overfit estimates in
the maximum likelihood case (lest we provide an inordinate amount of data). Even in
the age of big data, this can be an issue, as once we have appropriately sub-cohorted
by all relevant features, e.g. injury type, sex, race, age, weight, etc. we are left with
small sample sizes within each sub-cohort. Furthermore, certain sub-cohorts are prone
to having less data, e.g. severely injured patients usually have fewer test values available
because there was no time to collect data for those patients!
Hierarchical models are well known in Bayesian data analysis as an elegant solution to
this conundrum. This approach proceeds by treating sub-cohorts as separate entities with
their own respective parameters, but additionally modeling the dependence between the
groups with a common prior distribution over the parameters [57]. Hierarchical models
are very flexible because intuitively they can “adapt” to data by “shrinking” the value
of similar groups to a common value when data in a group is sparse, but they allow
parameter estimates to approach the value given by the data as more data is made
available. The hierarchical model includes as a special case the “full” model, where each
group gets its own parameter that is estimated separately, and a “null” model where each
group is treated as one big homogeneous group. Hierarchical models allow us to have a
model somewhere between these two extremes.
Hierarchical CCA In our probabilistic graphical model, we desire separate CCA pa-
rameters for each sub-cohort of injured patients. This calls for separate orthonormal
matrices for each sub-cohort, and thus for hierarchical modeling, a prior distribution
over orthornormal matrices. At least two distributions over orthornormal matrices exist
in the statistics literature [43]. One such distribution is the Matrix Langevin distribution.
Incorporating these distributions into a probabilistic graphical model and conducting in-
ference is difficult however, because evaluating their density functions involves computing
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the hypergeometric function of a matrix argument, a problem shown to be difficult even
for small matrices [58]. We detail in the following section how we use the Givens represen-
tation to build a hierarchical CCA model and perform joint analysis of the sub-cohorts.
4.3.4 Givens Representation for Graphical Models
Training of the model was done in Stan using Hamiltonian Monte Carlo (HMC)
sampling of posteriors for all latent variables and unknown parameters.
In order to conduct full Bayesian inference on weight matrices and set hierarchical
priors on such matrices, we require a way to sample on the space of orthonormal matrices,
preferably using a robust sampling method like HMC, a difficult problem in general due
to the constraint the samples of matrices must satisfy [40]. While methods exist for HMC
sampling of posteriors of general constrained parameters [38, 40], these methods treat
constrained and unconstrained parameters separately and require separate numerical
integrators for each type of parameter, making them difficult to implement in larger
probabilistic graphical models, with complicated priors, such as the model in described
in the preceeding section.
In order to sample posteriors of orthonormal matrices, we instead appeal to the
Givens representation introduced earlier. Because the Givens representation represents
orthornormal matrices as angles, we can place hierarchical priors over orthornormal ma-
trices in a straight-forward manner by simply placing priors over the angles. In our model
we do just that, placing truncated normal priors over the respective angles of each group
of injured patients. Our full probabilistic graphical model is similar to the model shown
earlier in Figure 4.1, but differs in that it contains four times as many group-level pa-
rameters, for the four different sub-cohorts described earlier. Furthermore, the truncated
normal prior acts as a hierarchical prior over the orthornormal matrices.
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4.4 Results
In the first sub-section we apply our model to plasma protein assays and TEG mea-
surements to find low dimensional descriptions of the coagulation system for each re-
spective sub-cohort of injured patients. We illustrate how in a probabilistic framework,
we can assess with confidence the differences in sub-cohorts, as well as assess how much
information our model captures, using posterior information. We then briefly describe
the affect of our hierarchical inference.
In the second subsection we explain how the shared subspace properties of CCA
may be used in a clinical setting to phenotype patients and guide treatment using TEG
measurements, without protein assays.
4.4.1 Finding Distinct Phenotypes of Coagulopathy
Table 4.1 shows point estimates of the orthornormal matrices of weights, Wprot and
Wteg, that relate the common latent variable, zs, to measured data, xprot and xteg, for
both the gun shot wound (GSW) and motor vehicle collision (MVC) sub-cohorts. Both
groups of patients share commonalities in their latent variables. For example, their first
latent variables correspond to high FactorII, FactorX, and platelets, but also to low TEG
K (speed of clot formation). On the other hand, the model captures differences between
the different groups, e.g. FactorX is a smaller component of the first latent variable in the
GSW sub-cohort than in the MVC sub-cohort. Full posterior inference provided by Stan
and the Givens transform allows us to compare these relationships probabilistically using
full posteriors rather than relying on point estimates (see Figure 4.2 for an example).
From full posterior draws we can simply count the number of posterior draws where the
FactorX weight parameter is higher in the GSW sub-cohort than the MVC sub-cohort,
giving us a posterior probability of 0.6, in this case of the statement being true, given
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Table 4.1: Point estimates for the orthornormal matrix of weights relating the com-
mon (between the protein and TEG data) latent variable to data for each respective
sub-cohort. Point estimates were obtained by taking the sample with the largest log
probability amongst all 20,000 posterior samples. Cells are colored by intensity of
estimated values. Red indicates a strong positive correlation, light red a weak pos-
itive correlation, blue a strong negative correlation, and light blue a weak negative
correlation.
GSW MVC
Proteins Latent 1 Latent 2 Latent 1 Latent 2
FactorII 0.47 -0.22 0.46 -0.38
FactorX 0.56 -0.09 0.82 0.05
ATIII 0.13 0.06 -0.02 0.57
D-Dimer -0.15 -0.95 -0.05 0.51
Fibrinogen 0.10 0.17 0.22 0.30
Platelets 0.64 -0.02 0.26 0.41
TEG
R -0.74 0.06 0.00 -0.03
K -0.42 -0.07 -0.84 0.14
MA 0.51 0.14 0.53 0.21
Ly30 -0.06 0.98 0.01 0.97
the data we observed.
Other differences between the two sub-cohorts are apparent in the point estimate of
the weight matrix. The model reveals that the second latent variable in the GSW sub-
cohort is tied strongly to low D-Dimer and low Ly30, while in the MVC sub-cohort the
second latent variable is actually tied to high D-Dimer and low Ly30. Figure 4.3 visually
illustrates this sub-cohort specific relationship our model was able to find.
In Figure 4.4 we compare posterior distributions of the “importance” parameters Λ
and Γ of each of the latent dimensions. The plot can be suggestive of different inherent
dimensionalities across the different subcohorts. For example the assault group has a
posterior for the weight of the second shared dimension that is closer to zero while the
GSW group’s weight for that same weight is concentrated more around a smaller positive
value, possibly indicating that of the GSW victims there is an extra dimension to be kept
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Figure 4.2: Densities estimated from posterior samples of the FactorX weight in the
matrix Wprot, in the GSW and MVC sub-cohorts respectively. These posterior results
indicate the MVC sub-cohort are represented by a latent dimension that places more
weigh on FactorX.
track of in their shared latent space.
Lastly, we make note of the shrinkage properties of the hierarchical prior. We con-
ducted separate, non-hierarchical inferences (not shown here) for the GSW group and
MVC groups and found that the posterior distributions of their parameters, in particular
the Wprot and Wteg matrices, were left relatively unchanged from the overall hierarchical
estimates shown here. These groups had 85 and 52 patients in them respectively. On
the other hand, we found much wider posteriors on parameters when estimating the as-
sault group, which consisted of only 16 patients, whereas the hierarchical estimate yields
narrower posteriors that are closer to the estimates of the other sub-cohorts.
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Figure 4.3: Relationship between D-Dimer and TEG Ly30 for different sub-cohorts
of patients. For gun shot wounds victims and stab wound victims (both penetrating
injuries) the two variables have a negative correlation where as for assault and motor
vehicle collisions (both blunt injuries) the relationship is slightly positive.
4.4.2 Using TEG and Injury Data to Predict Phenotypes
Intuitively, the hierarchical CCA model distills the information available in protein
and TEG data into shared latent components and ties together the relationship between
proteins and TEG by specifying how much of the information carried in these measure-
ments can be ascertained simply by knowing the values of the latent variables. For
example, in Table 4.1 we see that latent variable 1 of the GSW sub-cohort is tied to high
FactorII and FactorX levels in the protein category, and low R, low K, and high MA
in the TEG category. Thus intuitively, given values from a TEG test of a patient and
their injury type, we should be able to back out a posterior distribution of the underlying
protein values of that patient. In the case of a GSW victim with low R, low K, and high
MA, the CCA model suggests that there is a good chance that this patient could have
high FactorII and FactorX levels. This information on possible values of the underlying
protein levels could serve as valuable information in a real life trauma setting where in-
terventions are guided based on the state of the coagulation system. For example, plasma
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Figure 4.4: Posterior distributions of the “importance” parameters Λ and Γ of each of
the latent dimensions. In each facet we show a boxplot for the importance parameters
of latent dimension 1 and latent dimnension 2, using samples from their posterior
distributions. These weights describe the exploratory power the latent variables have
in describing our data (see methods section). The row of shared facets represent
importance weights for the latent variable that is shared between the protein and
TEG views while the row of TEG facets shows posteriors of importance weights for
the TEG-only latent variable.
transfusions are administered when it is thought that a patient’s Factor levels are low.
Figure 4.5 shows posterior draws of what a GSW patient’s FactorII will look like given a
TEG reading with low R, low K, and high MA.
The diagonal weight matrix Λ can also roughly tell us how much coagulation protein
information we can extract using TEG readings. High posterior values for the weights
connecting the shared latent variable to the protein data signify that variance in the
protein data can be readily explained by information that is shared between both the
protein and TEG views. Low values of those weights or high values of the Γ weights,
connecting the latent protein variables to the protein data, would signify that there is
information in the protein data that cannot be captured by the shared latent variable
and thus can not be captured by TEG.
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Figure 4.5: Posterior samples of estimated FactorII levels for a patient given their
TEG values.
4.5 Discussion and Related Work
Our results show how trauma data can be distilled into low dimensional latent compo-
nents in such a way as to respect the inherent difference in sub-cohorts of trauma patients.
We show how differences in different groups can manifest themselves in different models,
and how Bayesian posterior analysis of latent variable “weights” can be used to assess
the inherent dimensionality of data in different groups. We then showed the benefits of
hierarchical modeling as it pertains to our analysis, and why hierarchical modeling is an
essential tool when sub-cohorting. We ended with a possible use case of how understand-
ing the underlying relationship of coagulation proteins and TEG measurements via latent
variables can omcrease our understanding of coagulopathy and suggest improvements in
the treatment of trauma. While we acknowledge that sub-cohorting by injury type may
not be the optimal sub-cohort strategy, our method can be used in more general settings
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and especially in medicine where sub-cohorting is important to analysis.
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Chapter 5
Mechanistic Models
In this chapter we present our work titled “Relating Disparate Measures of Coagulapathy
Using Unorthodox Data: A Hybrid Mechanistic-Statistical Approach” from the proceed-
ings of StanCon Helsinki 2018 [59]. We first describe the nature of coagulopathy and
TEG measurements, and then describe our method of fitting ODE models to derived
data. Finally, we show results from applying this estimation procedure in practice.
5.1 Coagulopathy and TEG Measurements
Traumatic injury is the leading cause of death for people under the age of 44 [49].
Many of these deaths are the result of uncontrolled bleeding due to a trauma-induced
disorder called Acute Traumatic Coagulapathy, or known more simply as Coagulopathy
[50]. How major trauma causes Coagulapathy and how to treat the disease is still a
subject of ongoing research. There are various competing hypotheses for why so many
trauma patients are coagulapathic. The Coagulation Cascade and the Fibrinolytic system
are complex networks of dynamically interacting proteins in blood that are responsible
for forming and breaking up clots [53].
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Figure 5.1: Direct protein concetration measurements and TEG are used to examine
the state of the Coagulation Cascade of trauma patients using a small blood sample.
While direct protein measurements are obviously more informative of the exact state
of a patient’s blood at any given time, they are slow and expensive to obtain, compared
to TEG.
It is generally understood that Coagulopathy comes as a result of a malfunction in
one or both of these systems. To better study these complex networks, and how they are
affected during trauma, doctors and scientists have two major assays at their disposal:
direct protein concentration measurements and Thromboelastography, known as TEG
(Figure 5.1). Direct protein concentration measurements can tell us the concentration
levels of key players in the body’s coagulation system. Thus they can help us to under-
stand why a patient’s blood is not clotting and how they can be treated. Unfortunately,
these tests are available only at a very select number of hospitals specializing in trauma,
they are expensive to run, and most importantly they are slow to run in a setting where
applying the correct treatment as quickly as possible is of the utmost importance.
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In contrast to direct protein measurements, TEG measurements are ubiquitous, inex-
pensive to run, and can provide results in as little as 20 minutes. However, they do not
measure protein concentrations directly. Instead, TEG works by placing a small sample
of blood in a cup, chemically initiating the clotting process, then using a metal probe
to measure the physical size of the resulting clot over time in millimeters (mm) (Figure
5.2). The resulting output is a measure of clot thickness over time for the patient that
is indicative of several important features of their clotting state including:
• How long it takes for a patient’s blood to start forming a clot
• How fast the clot grows once clotting is initiated
• How strong the patient’s clots become
• How long the clots are able to maintain their integrity before being broken up
While TEG measurements clearly contain useful information regarding a patient’s
clotting state, they are simply a proxy for the latent system of clotting proteins in the
blood that is much more difficult to measure. Ideally, we can use our mechanistic un-
derstanding of the coagulation system in the form of Ordinary Differential Equations
(ODEs) along with a statistical model, to better understand what exactly TEG is telling
us about the state of the underlying coagulation system, and furthermore to infer a
patient’s protein concentrations using solely their TEG measurements.
Typically, mechanistic ODE models are fit in Stan using data that consists of the
states of the ODE over time, see e.g. [60] or [61]. In these settings one typically posits
an error distribution for the data that is centered around the forward simulated values
of the ODE. In contrast, our TEG data does not come in the form of clot thickness over
time, but rather in the form of four quantities derived from the clot thickness curve that
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Figure 5.2: In a TEG assay a small sample of blood is placed in a cup which is spun
around quickly to initiate the clotting process. A thin metal pin then measures the
size over time in millimeters (mm) of the resulting clot.
are typically used in the medical community to summarize the most important properties
of a TEG curve (Figure 5.3). These four quantities are described below:
1. R: The time (in minutes) for the clot to reach 2 mm. This quantity represents the
time it takes for the clotting process to initiate.
2. K: The time (in minutes) for the clot to reach 20 mm, from the time it reached 2
mm. This quantity represents speed of clot formation.
3. MA: The maximum amplitude of the clot i.e. the size of the clot when it is at its
largest. This quantity measures the strength of a patient’s clot.
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Figure 5.3: TEG curves represent the thickness of a clot over time and are summarized
by the four key quantities R, K, MA, and Ly30.
4. Ly30: The percentage of the clot which has broken down after 30 minutes as
compared to the maximum amplitude of the clot. This quantity measures how fast
clots are being broken up.
5.1.1 A Mechanistic Model of the Coagulation System
The coagulation system is well-studied, with several mechanistic ODE models in the
literature that describe how the system evolves dynamically over time. Models for the
coagulation system vary widely in the number of states, reactions, and parameters they
contain, including complex models with up to 80 states [62]. For our purposes we de-
veloped a simple reduced-order model based off of elements from both the work by [62]
as well as [63] that captures the most important players in the coagulation system. The
model includes the most basic components of the clotting process: the coagulation cas-
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Figure 5.4: A seven-state model of coagulation that models the clotting process, actual
clots, and the clot breakdown process. The rate of activation of FII in the coagulation
cascade is summarized by a delay term that is governed by parameters that are specific
to the patient.
cade responsible for forming clots, actual clot material, and clot breakdown or Fibrinolysis
(Figure 5.4).
We model the coagulation cascade as primarily consisting of the activation of the
blood protein FactorII (FII) to its activated form FIIa via the action of a sigmoid
delay function that is parameterized by parameters b and c. We model these parameter
values as specific to the patient. Importantly, FIIa can be blocked by antithrombin (AT ).
FIIa once activated can then facilitate the conversion of raw clot material, Fibrinogen,
or Fg in to an actual clot Fibrin, or Fn. Once a clot is formed, the clot can be broken
up by the protein tPA, which itself can be blocked by the protein PAI. The differential
equations for this model summarize this process and are shown below. Values for reaction
constants represent how fast these respective reactions occur with respect to one another.
The values we used for these constant were either gathered from the literature or fit using
Maximum A-Posteriori (MAP) estimation.
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dFII
dt
= −CascadeDelay(t, b, c) · TFPI(t) · FII
KFIIa + FII
(5.1)
dFIIa
dt
= CascadeDelay(t, b, c) · TFPI(t) · FII
KFIIa + FII
− kAT · FIIa · AT (5.2)
dAT
dt
= −kAT · FIIa · AT (5.3)
dFg
dt
= −kclot · FIIa · Fg
Kclot + Fg
(5.4)
dFn
dt
= kclot · FIIa · Fg
Kclot + Fg
− klys · tPA · Fn
Klys + Fn
(5.5)
dtPA
dt
= −kPAI · tPA · PAI (5.6)
dPAI
dt
= −kPAI · tPA · PAI (5.7)
(5.8)
5.1.2 A Mechanistic Model for TEG
While the model includes the concentration of Fn (Fibrin) which is a criticial com-
ponent of clots, the actual clot thickness which TEG measures is not measuring Fn per
se, but some function of it. Following [63], we used the Hill function
ClotThickness(t) = k
Fn2
K + Fn2
(5.9)
with k = 64.0 and K = 100.0 to translate Fn to clot thickness.
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5.2 Inferring ODEs Using Hitting Time and Max
Data
In the typical ODE estimation setting, where our data consists of the value of the
ODE states over time, yn, n = 1, · · · , N there typically is a likelihood of the form
N∏
en=1
p(yn|y(sim)n (y0, θ)), (5.10)
where y
(sim)
n (y0, θ) is a forward simulation of our ODE, given the initial conditions y0 and
the parameters θ. The Hamiltonian Monte Carlo (HMC) algorithm requires the gradient
of the likelihood with respect to the quantities we are trying to estimate, in this case y0
and θ.
In the case of TEG in coagulapathy, the data consists of hitting times, such as the
quantity R, which represents the time it takes for a patient’s clot to reach a size of 2
mm. Thus, in a probabilistic model, the likelihood must instead take the form
p(R|R(sim)(y0, θ)). (5.11)
For HMC to obtain the correct gradients of this likelihood, care must be taken in
computing the hitting time Rsim(y0, θ). First, note that a numerical ODE solver will
return the value of the solution at discrete time points, which in the case of of TEG,
are used to compute clot thickness, Cn at the discrete time points t1, · · · , tN . R is a
continuous value formally defined as
R := inf{t : C(t|y0, θ) > 2.0}, (5.12)
which unfortunately does not have a smooth derivative with respect to the initial condi-
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tions and unknown parameters. In practice, this would cause problems for HMC, because
the log-likelihood should be a smooth function of the unknowns, and ideally have smooth
derivatives as well.
To ameliorate this, the discrete solution points can be utilized {Cn(y0, θ)} to ob-
tain a continuous function C(t|y0, θ) by interpolating the solution points using cubic
splines. The interpolated function will have two smooth derivatives, allowing HMC to
run smoothly.
5.2.1 Using Cubic Splines to Obtain Continuous ODE Solutions
Fortunately, the Stan language is expressive enough to allow us to easily implement
code for computing a smooth function C(t) that interpolates through the discrete points
Cn, n = 0, · · · , N defined at the points t0, · · · , tN . In particular, we can write a function
in Stan to fit a cubic interpolating spline through a given set of points. We provide a
quick review of cubic smoothing splines and how to compute them loosely following the
exposition in [64].
Our aim is to derive the functional form of a group of cubic splines s3,i−1(t) over the
intervals [ti−1, ti]. The functions will be cubic polynomials and will be twice differentiable,
even at the nodes t0, · · · , tN . We first define fi = s3(ti), mi = s3(ti), and Mi = s′′3(ti) for
i = 0, · · · , N . Since s3,i−1 is a cubic polynomial, its second derivative is linear. Since the
cubic spline must have continuous second derivatives we have
s′′3,i−1(t) = Mi−1
ti − t
hi
+Mi
t− ti−1
hi
(5.13)
for t ∈ [ti−1, ti] where hi = ti − ti−1. Integrating twice we obtain
s3,i−1(t) = Mi−1
(ti − t)3
6hi
+Mi
(t− ti−1)3
6hi
+ Ci−1(t− ti−1) + C˜i−1 (5.14)
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The constants Ci−1 and C˜i−1 are uniquely determined by imposing the end point
values s3(ti−1) = fi−1 and s3(ti) = fi, yielding for i = 1, · · · , N − 1
C˜i−1 = fi−1 −Mi−1h
2
i
6
(5.15)
Ci−1 =
fi − fi−1
hi
− hi
6
(Mi −Mi−1). (5.16)
By imposing continuity of the first dervivatives at the nodes we arrive at the linear
system
µiMi−1 + 2Mi + λiMi+1 = di, i = 1, · · · , N1, (5.17)
where
µi =
hi
hi + hi+1
(5.18)
λi =
hi+1
hi + hi+1
(5.19)
di =
6
hi + hi+1
(
fi+1 − fi
hi+1
− fi − fi−1
hi
)
(5.20)
for i = 1, · · · , N − 1. Setting λ0 = µN = 1 and d0 = d1 leads to the following linear
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system which defines our spline coefficients:

2 λ0 0 · · · 0
µ1 2 λ1
. . .
...
0
. . . . . . . . . 0
...
. . . µN−1 2 λN−1
0 · · · 0 µN 2


M0
M1
...
MN−1
MN

=

d0
d1
...
dN−1
dN

(5.21)
Because this system is tridiagonal, we can solve it in O(N) time using the Thomas
algorithm [64].
5.2.2 Obtaining Hitting Times from the Spline Interpolation
With our continuous clot thickness function in hand, we are now able to compute
stopping times that are a smooth function of our unknowns by using an algebraic solver
on our continuous function and appealing to the implicit function theorem. Letting
C(t|y0, θ) represent our spline function that interpolates the discrete points Cn(y0, θ), R
is defined implicitly as
C(R(y0, θ)|y0, θ) = 2.0. (5.22)
Note that R, the time that the clot hits 2.0 mm is dependent on the initial value of
the system, as well as the parameter values of the system. Taking the partial derivative
of both sides of the equation with respect to θ yields
∂
∂R
C(R|y0, θ)∂R
∂θ
+
∂
∂θ
C(R|y0, θ) = 0.0, (5.23)
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which then yields the correct partial derivative we need for HMC:
∂R
∂θ
= − ∂
∂θ
C(R|y0, θ)
(
∂
∂R
C(R|y0, θ)
)−1
. (5.24)
This solve can be accomplished and the correct partial derivative will be used in
Stan’s HMC implementation by simply passing the function C(t) to the algebraic solver
available in Stan which uses a modified version of Newton’s method to find the solution
of nonlinear systems of equations [65].
Because Newton Iterations may diverge with a poor starting guess, and at the time
of this writing Stan’s algebraic solver does not support variable initial guesses, we opted
to implement a custom C++ solver based off of the bisection method.
5.2.3 Obtaining the Max of Our Spline Function
Note that the MA, or maximum amplitude TEG values also requires a nonlinear solve
to obtain. To compute this value we also use custom C++ code based off of the bisection
method on the derivative of the function. In this case the appropriate gradient can be
computed similarly.
5.3 Inferring Hybrid Mechanistic-Statistical Models
and the Unorthodox Nature of TEG Data
To use the derived quantities in TEG to infer unknown parameters and initial condi-
tions, we must first forward simulate the ODE, compute the clot thickness as a function
of fibrin concentration, Fn, then use the trajectory of clot of thickness over time to de-
rive our simulated TEG data, which we finally can compare to our data by positing some
statistical model. We describe the finer points of this process in the following section.
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5.3.1 Inferring Protein Concentrations Using TEG Data
Recall, our goal of inferring patient initial concentration of tPA given their TEG
measurements. In theory this should be possible because tPA is a protein primarily
responsible for clot breakup and the Ly30 measurement of TEG measures the amount of
clot breakup after 30 minutes. In this case, the patient has an unusually high Ly30 value
of 1.7, indicating that 1.7% of their clot already broke up after only 30 minutes. In light
of this, we should expect this patient to have a higher than average tPA concentration.
5.3.2 Prior Selection
Recall that in our mechanistic model every patient has ”cascade delay” parameters b
and c that describe the specific state of the coagulation cascade. Using our four pieces
of TEG data, we must infer the two parameters and also the value of the unknown
protein concentrations tPA and PAI for our patient. To do this reasonably, it helps
to incorporate any prior knowledge we have about these parameters. For the protein
concentrations, we set the prior distributions to exponential distributions with respective
means 4e-10 and 9.3e-10. These are the distributions of these protein concentrations
for general trauma patients. With the information given it’s reasonable to assume our
trauma patient’s protein values are drawn form the distribution of protein values for
trauma patients. For b and c, we use weakly informative priors that are representative
of a wide variety of possible coagulation profiles that we would expect to see in trauma
patients.
5.3.3 Posterior Analysis
With priors set, the model can be fit, integrating our prior knowledge and data to pro-
duce a posterior distribution of this patient’s tPA values. Figure 5.5 compares prior and
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Figure 5.5: Posterior versus prior distribution of tPA values.
posterior tPA values for the example patient. This patient’s tPA concentration is higher
than the population average, which we used as our prior distribution. This is reflective of
their relatively high Ly30 value, as expected. This posterior shrinkage is indicative of the
information provided in the data as well as the population-level distributions. We note
that the patient data also informs the parameters of the population-level distribution
through the estimation of the individual patient parameters.
5.3.4 Discussion
We showed how one can tackle the very practical problem of tying together disparate
measures of coagulopathy by incorporating mechanistic and statistical knowledge into
Stan. In particular, we showed how TEG data, which consists of unorthodox measure-
ment quantities, can be used to infer much less ubiquitous but more informative protein
data with clever use of techniques from numerical analysis such as splines, root-finding,
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and the inverse function theorem.
We fit a model to a single patient, first to illustrate our tying together of various nu-
merical techniques, and second to show how a mechanistic model together with Bayesian
analysis in Stan can be used in a practical clinical setting to infer useful information. In
a larger study, for the purpose of more specific model callibration/checking it may be
useful to fit multiple patients, forward simulate TEG data, and check callibration quan-
tities with respect to uncertainty intervals to ensure that modeling and distributional
assumptions are sound. We did not pursue this further as it was outside of our scope,
but we mention it for completeness.
We also point out that our priors for the protein concentrations were selected using
an empirical Bayes approach where we fit a point estimate to protein data from an entire
population of patients we had data for. In a sense, this is a computationally convenient
approximation to a hierarchical model which would simultaneously incorporate data from
multiple patients and learn the population level distributions.
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Implicit Hamiltonian Monte Carlo
We describe our recent work on multiscale posterior distribution and HMC titled “Im-
plicit Hamiltonian Monte Carlo for Sampling Multiscale Distributions” submitted the
Springer Journal of Statistics and Computing [66]. Hamiltonian Monte Carlo (HMC)
has been widely adopted in the statistics community because of its ability to sample
high-dimensional distributions much more efficiently than other Metropolis-based meth-
ods. Despite this, HMC often performs sub-optimally on distributions with high cor-
relations or marginal variances on multiple scales because the resulting stiffness forces
the leapfrog integrator in HMC to take an unreasonably small stepsize. We provide
intuition as well as a formal analysis showing how these multiscale distributions limit
the stepsize of leapfrog and we show how the implicit midpoint method can be used,
together with Newton-Krylov iteration, to circumvent this limitation and achieve major
efficiency gains. Furthermore, we offer practical guidelines for when to choose between
implicit midpoint and leapfrog and what stepsize to use for each method, depending on
the distribution being sampled. Unlike previous modifications to HMC, our method is
generally applicable to highly non-Gaussian distributions exhibiting multiple scales. We
illustrate how our method can provide a dramatic speedup over leapfrog in the context
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of the No-U-Turn sampler (NUTS) applied to several examples.
6.1 Introduction
The Hamiltonian Monte Carlo (HMC) algorithm [6] and its recent successor, the No-
U-Turn (NUTS) sampler [10], have seen widespread use recently in the statistics commu-
nity because of their proficiency in sampling high-dimensional distributions. In fact, [9]
showed that as the dimension, D, of the distribution p(q) being sampled tends to infin-
ity, HMC requires only O(D5/4) samples to sufficiently explore the distribution, while the
classic random-walk Metropolis algorithm [8] requires O(D2). Roughly speaking, HMC
and NUTS achieve this efficiency gain because rather than exploring parameter space in
a random fashion, they systematically explore level-sets of Hamiltonian energy by using
the leapfrog integrator to numerically simulate Hamiltonian dynamics over the potential
energy surface defined by U(q) = − log p(q) [7]. While the Hamiltonian energy remains
roughly constant over these level sets, when simulating Hamiltonian dynamics using the
leapfrog integrator, the log-probability density and values of the random variables q often
vary quite widely in practice, yielding samples that are much closer to independent than
samples from the random-walk Metropolis algorithm [67].
The key to HMC reaching the correct stationary distribution lies in the reversibility
of the leapfrog integrator that allows the Markov transitions to satisfy detailed-balance.
Furthermore, the leapfrog integrator is volume-preserving in phase-space, which makes
the computation of the Metropolis probabilities in HMC trivial [7]. In fact, the leapfrog
integrator belongs to a class of numerical integrators known as symplectic integrators
that exhibit both of these properties along with a more general property known as sym-
plecticity. Symplectic integrators have been well-studied [39, 68]. However, little work
has been done to characterize how the properties of a probability distribution relate to
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the properties of the associated Hamiltonian system in HMC, and how these properties
make certain integrators more advantageous than others, depending on the problem.
To this end, we provide an analysis of how and why the geometry of Bayesian posterior
distributions with low variance components can lead to multiscale Hamiltonian systems,
i.e. systems with rapidly oscillating components that force leapfrog to take a much
smaller stepsize than what would otherwise be possible with an implicit integrator. We
describe the implicit midpoint integrator as an alternative to leapfrog for these types of
problems, and show how to practically implement it in an HMC context. Furthermore, we
offer practical guidelines on the stepsize to choose when using either leapfrog or implicit
midpoint in an HMC sampler, as well as heuristics for when to choose one algorithm over
the other. Finally, we compare, using practical examples, the efficiency of leapfrog NUTS
(lfNUTS) with an implicit NUTS implementation we introduce called iNUTS. Code for
these experiments is available as an R package that can be obtained by emailing the
authors.
In Section 6.2 we provide a brief introduction to HMC and then describe the concept
of numerical stability of an integrator and how it connects to the geometries of multivari-
ate distributions in HMC. In Section 6.3 we describe the symplectic implicit midpoint
algorithm along with our practical custom implementation specific to HMC. We also de-
rive the mathematical stability limit for the implicit midpoint algorithm, showing how
it provides a clear advantage over leapfrog on multiscale systems. In Section 6.4 we
show how in practice, using real examples, our iNUTS implementation leads to less com-
putational work per effective sample than leapfrog-based NUTS on common multiscale
systems. We conclude with a summary of our contributions and future directions in
Section 6.5.
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Related Work: While various works have explored modifications of the leapfrog in-
tegrator in HMC, the connection between posterior geometry and integrator choice as
well as the multiscale problem has been sparsely examined. On the statistics side, both
[69] and [70] adapted the leapfrog integrator in HMC by splitting the potential energy
into a Gaussian term and a non-Gaussian term, which are integrated separately. While
these methods can alleviate the multiscale problem for distributions that can be well-
approximated by a Gaussian, they fail to offer an efficiency gain over leapfrog for more
complicated distributions, as we describe in Section 6.2. Our implicit midpoint-based
method is able to achieve efficiency gains over leapfrog on a more general class of prob-
lems.
Okudo et al. [71] modify the leapfrog integrator in HMC by adding an auxiliary
variable that allows for online adaptation of the stepsize. The RMHMC method of [72]
uses local Hessian information of the potential energy function to adaptively change
the mass matrix of HMC, which is equivalent to adaptively changing leapfrog stepsizes.
While both of these methods can effectively adapt the stepsize in leapfrog to the local
geometries of non-Gaussian distributions, they are still subject to using a small integrator
stepsize in a multiscale problem, just as standard leapfrog is. In contrast, our implicit
midpoint-based approach has much less severe stepsize limitations [73].
6.2 Hamiltonian Monte Carlo and Numerical Stabil-
ity in a Multiscale Problem
We provide a brief overview of the basic HMC algorithm and how it leads to a
Hamiltonian system of ODEs. We then provide a short explanation and illustration
of numerical stability of the leapfrog integrator on a linear Hamiltonian system, and
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then extend this analysis to show how stability can be a crucial bottleneck in multiscale
systems. Finally, using the linearization of arbitrary Hamiltonian systems, we extend
the multiscale concept to non-Gaussian distributions and draw the connection between
posterior geometry and the mass matrix of HMC. For a more comprehensive review of
HMC, see [7]. For a more recent review that includes an exposition on NUTS, see [67].
For a more thorough review of stability analysis for the numerical solution of Hamiltonian
systems see [39, Ch. 2.6].
6.2.1 Hamiltonian Monte Carlo
HMC provides samples from an arbitrary distribution over q ∈ RD with density p(q)
by taking Markov transitions that satisfy detailed-balance with respect to p(q). In HMC,
a potential energy surface U(q) = − log p(q) is defined, along with a kinetic energy,
K(p) := pTM−1p, and a Hamiltonian, H(q, p) := U(q) +K(p). Given a starting point q0
on this surface, an HMC transition begins by sampling a random momentum, p0 ∈ RD,
from a multivariate normal distribution with mean zero and covariance M [67]. Given
these initial values q0 and p0, the Hamiltonian system
q′ =
∂H
∂p
= M−1 (6.1)
p′ =
∂H
∂p
= −∇q U(q)
is solved, resulting in a new set of points q1 and p1 in phase-space, as shown in Figure
6.1. The point q1 is then accepted or rejected as a new sample of the distribution, in
typical Metropolis fashion using the acceptance probability defined by
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Figure 6.1: Given a starting point q0, an HMC proposal starts by drawing a mo-
mentum, p0, then simulating Hamiltonian dynamics for a fixed time to reach a new
proposal, (q1, p1). A Metropolis accept-reject step is then used to accept the new pro-
posal randomly, depending on the difference between the Hamiltonian at the original
point in q-p space and the Hamiltonian at the proposed point.
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min {1, exp (H(q0, p0)−H(q1, p1))} . (6.2)
In classical HMC, the dynamics defined in (6.1) are simulated by applying discrete
steps of the leapfrog integrator for T steps. These leapfrog steps are discretized by a
stepsize h, yielding
qn+1 = qn + hM
−1pn − h
2
2
M−1∇q U(qn) (6.3)
pn+1 = pn − h
2
∇q U(qn)− h
2
∇q U(qn+1).
These update equations crucially provide a reversible and volume preserving tran-
sition due to the symplectic property of the leapfrog integrator [7]. Moreover, for a
satisfactory stepsize the Hamiltonian, H(q, p), remains nearly constant over the numeri-
cal simulation of the Hamiltonian dynamics.
6.2.2 Numerical Stability
In practice, the stepsize of the leapfrog integrator is limited by its numerical stability,
which is problem-dependent. This concept is easiest to illustrate using a simple system
derived from a univariate Gaussian. Specifically, for a univariate Gaussian distribution
with mean zero and variance σ2, the potential energy function used in HMC is U(q) =
qTΣ−1q. For an identity mass matrix, this leads to the following leapfrog update rule:
qn+1 = qn + hpn − h
2
2
σ2qn (6.4)
pn+1 = pn − h
2
σ2qn − h
2
σ2qn+1,
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Figure 6.2: For stepsizes larger than the stability threshold of the problem, the leapfrog
method goes unstable, leading to wild numerical solutions whose errors characteristi-
cally grow after each step (green trajectory). This is in contrast to numerical solutions
below the stability threshold, for which the error stays bounded after a series of steps
(red trajectory).
which can be compactly written in matrix form as
qn+1
pn+1
 =
 1− h22 σ2 h
−hσ2(1− h2
4
σ2) 1− h2
2
σ2

qn
pn
 . (6.5)
The update matrix in (6.5) describes how leapfrog advances forward one step, for a
univariate Gaussian system with mass one. Because the leapfrog method is symplectic,
the determinant of this matrix is always one. However, for h < 2/σ the eigenvalues
are complex and have modulus equal to one, while for h > 2/σ they are real with
one of the eigenvalues having modulus greater than one [39, Ch. 2.6]. The latter case
results in numerical instability of the integrator [39]. Intuitively, this means that any
small numerical errors that will inevitably arise in the numerical solutions (qn, pn) will
be successively “magnified” by each application of the leapfrog update matrix, quickly
resulting in a solution with unacceptably large error (Figure 6.2).
The univariate analysis can be readily extended to a multivariate Gaussian of dimen-
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sion D with covariance matrix Σ. With a mass matrix equal to the identity, this results
in the following Hamiltonian system:
q′ = p (6.6)
p′ = Σ−1q.
In general, Σ−1 may have off-diagonal correlation terms that make this derived system
coupled. However, the transformation defined by u := V −1q and w := V −1p, where V
is a matrix whose columns consist of the eigenvectors of Σ−1, essentially uncouples the
differential equations, yielding
u′ = w (6.7)
w′ = Λu,
where Λ is a diagonal matrix composed of the eigenvalues, λ1, · · · , λD, of Σ−1 [39, Ch.
2.6]. This decoupling transformation can be thought of as reparameterizing the problem
so that the potential energy surface exhibits no correlation (Figure 6.3).
Applying the leapfrog update rule (6.3) to the uncoupled equations (6.7) elucidates
how the issue of numerical stability arises in the case of a multivariate Gaussian. Specif-
ically, if one or more of the eigenvalues of Σ−1 do not satisfy the inequality h < 2/
√
λi,
then the leapfrog update matrix will have a real eigenvalue with modulus greater than
one, and instability in the numerical integration will arise. In practice this will lead to
poor acceptance rates in the Markov chain as well as to divergences [67]. Formally, for
leapfrog on a multivariate Gaussian with mass matrix I the stepsize h must satisfy the
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Figure 6.3: A decoupling transformation is equivalent to transforming a correlated
distribution (left) to an uncorrelated one (middle). Similarly, a transformation can be
used to make an arbitrary Gaussian isotropic (right).
inequality
h < 2/
√
ρ(Σ−1) (6.8)
to ensure stability (here ρ(Σ−1) denotes the spectral radius of Σ−1, defined as the maxi-
mum of the absolute value of its eigenvalues).
This condition can severely limit the timestep of leapfrog. Intuitively, the dimensions
of the distribution that exhibit high variance, and thus low curvature in the potential
energy surface, will have slowly oscillating Hamiltonian trajectories that are very smooth
and can be integrated by leapfrog with a reasonable stepsize. Meanwhile, dimensions
with low variance, and thus high curvature, will lead to rapdily oscillating solutions that
require a very small stepsize. Thus a system that has even one state with a dramatically
smaller variance than the others will force leapfrog to take excessively small steps on
the whole system. An ODE system that exhibits this sort of behavior is known as a
multiscale system [74]. In practice, the telltale sign of a distribution that will lead to a
multiscale Hamiltonian system in HMC is the inverse covariance matrix, Σ−1 having a
large condition number. The condition number κ(Σ−1) is defined as the ratio of the largest
eigenvalue of Σ−1 to the smallest. Intuitively, it captures the ratio of the curvatures of the
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dimensions of the potential energy surface. Practically speaking, a large condition number
can arise either when an uncorrelated Gaussian has a large disparity in the variance of its
largest and smallest dimensions, or alternatively when a multivariate Gaussian contains
high correlations between dimensions. In engineering, the multiscale problem is often
resolved by using an appropriate implicit integrator, which is typically able to take much
larger steps on multiscale problems while preserving the accuracy of desired quantities
of the system [73, 75]. We describe this approach and its application to HMC in the
following section.
6.2.3 Nonlinear Posterior Geometry
While the stability analysis considered so far has been only for Gaussian distributions
which result in linear Hamiltonian systems, most practical distributions being sampled by
HMC are not Gaussian and thus result in nonlinear Hamiltonian systems. For nonlinear
systems, one can locally identify a multiscale system by analyzing the condition number
of the local Hessian of the potential energy surface, ∇qqU(q). This local Hessian is
equivalent to the inverse covariance matrix of the local Laplace approximation to the
posterior [1, Chapter 4]. Thus the key difference between the posterior geometry of a
Gaussian distribution and that of a more complicated distribution is that the former has
a potential energy surface with a constant Hessian while the latter may contain vastly
different local Hessians throughout the surface, which can lead to different multiscale
properties of the associated Hamiltonian system (Figure 6.4). In practice, this means
that different leapfrog stepsizes may be required, depending on where on the potential
energy surface the sampler is currently located. Roughly speaking, RMHMC uses local
Hessian evaluations of the potential energy surface to adaptively change this stepsize
based on the local curvature [72].
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Figure 6.4: Unlike a Gaussian distribution, arbitrary non-Gaussian distributions have
non-constant local Hessians (here characterized by the green eigenvectors of the local
Hessian multiplied by their associated eigenvalues) that affect the oscillatory frequency
of HMC trajectories and thus an acceptable leapfrog stepsize.
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6.2.4 The Mass Matrix as a Reparameterization
Although a multivariate Gaussian system exhibiting multiple scales can significantly
hinder the efficiency of the leapfrog method, this deficiency may be resolved by appro-
priately selecting the mass matrix M in (6.1). In fact, utilizing a mass matrix in HMC
that is equal to the covariance Σ of the Gaussian is equivalent to reparameterizing the
problem to an equivalent isotropic Gaussian [7] (Figure 6.3). From a numerical analysis
perspective, M−1 can be viewed as a preconditioner that transforms the problem so as to
give Σ−1 a better condition number κ(Σ−1), i.e. it transforms the problem so that there
is less discrepency between the largest and smallest eigenvalues of Σ−1.
While a conveniently selected mass matrix can effectively eliminate the multiscale
problem of leapfrog for Gaussian distributions, for distributions with more complicated
geometry whose local curvature varies, a constant mass matrix is inherently much less
effective in accounting for multiscale geometry. Splitting methods such as that of [69] as
well as [70] which can handle high curvature and multiple scales by separating out a con-
stant Gaussian approximation of the distribution unfortunately have the same limitation,
as they cannot handle the varying curvature of non-Gaussian posteriors.
6.3 Implicit HMC
The stability bottleneck placed on leapfrog by a multiscale system is characteristic
of explicit integrators like leapfrog. In the ODE community, implicit integrators have
been used to essentially “skip” fast oscillations while accurately evolving in time quan-
tities of interest in the system [73, 75]. We describe the implicit midpoint integrator:
a symplectic alternative to leapfrog that is of the same order of accuracy as leapfrog,
but is implicit, allowing it to take much bigger timesteps on multiscale problems than
what would otherwise be possible with leapfrog. Unlike the approaches of [69] and [70],
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the implicit midpoint integrator is applicable to arbitrary multiscale systems, not just
Gaussian ones.
We explain how, unlike leapfrog, the implicit midpoint method has no stability limit
on a linear system. We then describe a custom Newton-Krylov method for the solution
of the nonlinear system that must be solved at each timestep by midpoint. Finally, we
point out that while the implicit midpoint method is unconditionally stable on a linear
system, in practice it can go unstable on nonlinear problems [73], although at a much
larger stepsize than leapfrog is able to take. We discuss the practical implications of this
and aspects of choosing between leapfrog and implicit midpoint for a specific problem,
and we give practical guidelines for selecting a stepsize for both methods.
6.3.1 Implicit Midpoint and Stability
For general Hamiltonian systems of the form in equation 6.1, the timesteps of implicit
midpoint are defined by
qn+1 = qn + hM
−1
(
pn + pn+1
2
)
(6.9)
pn+1 = pn − h∇q U
(
qn + qn+1
2
)
.
Because the point (qn+1, pn+1) is defined implicitly, as opposed to in leapfrog where
an explicitly computable update equation is given, one must resort to either functional
iteration or Newton’s method to compute its value. However, in situations where im-
plicit midpoint would be desirable over leapfrog, Newton’s method or a more robust
modification of it is typically preferred [74, ch. 3.4.2]. We elaborate on this point in the
subsequent subsection.
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Figure 6.5: Unlike the leapfrog integrator which goes unstable for large enough step-
sizes (green trajectory), the implicit midpoint integrator can remain stable at the
same stepsize (red trajectory) and even at stepsizes much larger than the stability
threshold for leapfrog (purple trajectory).
An analaysis that is similar to the one performed for leapfrog in Section 6.2.2 shows
that unlike leapfrog, the implicit midpoint method does not have a stability limit on the
linear system that arise from HMC sampling of a Gaussian distribution. In fact, like the
update matrix for leapfrog, the update matrix for midpoint on a Gaussian distribution
always has determinant one, however it can be shown that its eigenvalues are complex for
any stepsize, h (see the Appendix for a full analysis of the stability of implicit midpoint
for linear Hamiltonian systems). In other words, the implicit midpoint method is stable
on Gaussian systems for any stepsize, i.e. it has not stability limit (Figure 6.5).
6.3.2 Fast Solution of the Nonlinear System
As previously mentioned, (6.9) must typically be solved for (qn+1 pn+1) numerically.
In practice this can be done by applying Newton’s method to solve equation 6.9, however
this can be costly for large systems. First, because the first D equations in 6.9 are linear,
one can substitute the first D equations into the second D to obtain the nonlinear system
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6.10 with D equations and the D unknowns, pn+1. Once pn+1 is obtained, qn+1 can be
obtained by simply plugging the result back into the first set of equations, yielding
pn+1 = pn − h∇qU
(
qn +
h
4
M−1(pn + pn+1)
)
. (6.10)
Renaming pn+1 to x and noting that pn is known from the previous timestep, equation
(10) can be written as
g(x) := x− pn + h∇qU
(
qn +
h
4
M−1(pn + x)
)
. (6.11)
Newton’s method applied to this system consists of starting with an initial guess, x0,
and iteratively obtaining approximate solutions x1, x2, · · · using the following steps until
a convergence criteria is reached:
1. Solve the linear system Jg(xn)δ = −g(xn)
2. Set xn+1 = xn + αδ,
where for the standard Newton iteration α = 1. Here, Jg(xn) refers to the Jacobian of g
evaluated at xn and is given by
Jg(x) := I +
h2
4
∇qqU
(
qn +
h
4
M−1(pn + x)
)
M−1. (6.12)
For large systems, exploitation of the structure of the system is critical for both efficiency
and robustness. We introduce the Newton-Krylov method, which is particularly well-
suited to this class of problems.
Newton-Krylov Methods
In the classic Newton method, the linear solve step requires explicitly computing
Jg(xn) and carrying out a full linear solve of the equation Jg(xn)δ = −g(xn) for δ at each
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Newton iteration. This requires evaluating the Hessian ∇qqU(q) of the potential energy,
which scales as O(D2). A Newton-Krylov method [76] circumvents this expensive linear
solve that occurs at every Newton iteration by replacing the linear solve with an ap-
proximate linear solve that is much cheaper to compute. Specifically, the Newton-Krylov
method replaces the solution δ with an approximate solution δ˜ such that ‖Jg(xn)δ˜+g(xn)‖
is less than some tolerance, ηn, otherwise known as a “forcing term”. This forcing term is
typically selected using a scheduling criteria that satisfies certain theoretical properties.
For our experiments we found the most success with method 2.1 of [77], as it did not rely
on manually selected “tuning parameters”.
In our iNUTS implementation, we use the GMRES solver [78] to compute the approx-
imate linear solves within the Newton-Krylov iterations. The GMRES algorithm works
by iteratively computing approximate solutions to the linear system Jg(xn)δ = −g(xn)
that reduce the norm ‖Jg(xn)δ + g(xn)‖, while needing only to evaluate the product of
the matrix Jg(xn) with an arbitrary vector v.
Needing only to evaluate the product of the matrix Jg(xn) with an arbitrary vector
v, rather than computing Jg(xn) and then computing its product with v, is particularly
advantageous in HMC for two reasons. First, the Jacobian vector product Jg(xn) · v can
be evaluated using only a Hessian-vector product of the potential energy which, in an
efficient automatic differentiation implementation such as the one available in Stan [11],
scales as O(D) as opposed to computing a full Hessian, which scales as O(D2). Second,
the iterated solutions in a Krylov-based solver are known to converge faster when the
matrix Jg(xn) has “clusters” of eigenvalues that are close together [79], as is the case
when the system being solved comes from the posterior of a Bayesian model, particularly
a multilevel Bayesian model. Specifically, in the case of implicit midpoint applied to HMC
on the posterior of a Bayesian multilevel model, the matrix (6.12) will have clusters of
eigenvalues that are all of similar order and correspond to the units in a multilevel model
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that are are all at the same level. For example, for the famous “eight schools” model in
[1], there is a variance parameter τ that is at the scale of 1, and eight separate school-
level parameters at the scale of 10. Although there are nine parameters total, and thus a
nine-by-nine system to solve, in practice the Newton-Krylov method can typically solve
the linear system to numerical precision in only two iterations, because there are only
two “clusters” of eigenvalues in the Hessian: the cluster at the scale of 1 and the cluster
at the scale of 10.
Using a Line Search
The second modification we make to the classic Newton method is to change the
steplength α of the Newton iteration to ensure that consecutive iterations of the Newton-
Krylov method effectively reduce the residual error in the nonlinear system. In particular,
we use a geometric line-search to continually halve the size of α until the new solution
satisfies the Armijo-Goldstein condition [64].
Choosing an Initial Guess
While not a modification of Newton’s method per se, in our iNUTS implementation we
also use a unique method of setting the initial guess x0 to the nonlinear solver. In practice,
this greatly improves the number of Newton-Krylov iterations needed for convergence.
In particular, we exploit the numerical properties of the implicit midpoint integrator on
multiscale systems, to obtain a good initial guess. Specifically, when the stepsize h of
the numerical integrator is small relative to the local frequency of a particular oscillating
momentum coordinate p(i), the previous momentum, p
(i)
n , will serve as a good initial guess
to p
(i)
n+1 in the system 6.10, as the numerical solution will not be changing much between
consecutive steps. Similarly, the second to last momentum p
(i)
n−1 will also serve as a good
initial guess, although not quite as good as the last value. On the other hand, when h is
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much larger than the frequency of a particular oscillating variable p(i), which will be the
case in a multiscale system, the numerical solution will approximately “alternate” about
zero taking on the values p
(i)
1 = γ, p
(i)
2 = −γ, p(i)3 = γ, · · · . Thus in this case, the second
to last momentum serves as a good initial guess. Thus we use pn−1 as an initial guess
overall for the nonlinear equation solver.
6.3.3 Nonlinear Stability Limit and Choosing an Integrator and
a Stepsize
While the implicit midpoint method is unconditionally stable for any stepsize h on a
linear system, it can and will exhibit instability for certain nonlinear systems, although
typically at a stepsize that is much larger than the stepsize at which leapfrog would go
unstable on the same problem [73]. In practice, these instabilities can typically be identi-
fied by observing large growth in the Hamiltonian of the numerical numerical trajectory,
or when Newton-Krylov iterations fail to converge. To find an appropriate stepsize for
implicit midpoint in practice, we recommend running a sampler “warmup” period where
the stepsize h is reduced by some factor like 1/2 until these pathological behaviors are
eliminated. This is akin to the current warmup method of Stan, where the stepsize of
the integrator is reduced until an acceptable accept rate is reached [11].
To select between implicit midpoint and leapfrog on a specific problem, we suggest
starting with implicit midpoint and periodically calculating an approximation to the
largest eigenvalue of the local Hessian of the potential energy function during a warmup
period. This eigenvalue approximation can be efficiently computed with only a few
Hessian-vector products using the power method of numerical linear algebra [79]. This
can in turn be used to get an approximation of the largest stepsize that leapfrog could
take while maintaining stability, via equation 6.8. When the smallest of these approxi-
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mate stepsizes divided by two is close to the implicit midpoint stepsize needed to maintain
stability divided by the average number of gradient evaluations plus Hessian-vector prod-
ucts required by implicit midpoint, then the leapfrog method will be more efficient for the
problem. This is because the leapfrog method requires two gradient evaluations per step,
and a Hessian-vector product, like a gradient evaluation, scales linearly in the number of
inputs to an automatic differentiation system such as the one used in Stan. In practice,
we found that computation of the Hessian-vector product took 1.2-1.3 times the cost of
a gradient evaluation in Stan.
6.4 Experiments
We illustrate on several examples how implicit midpoint can achieve superior effi-
ciency over leapfrog on multiscale problems. For all of our examples we compare using a
custom implementation of NUTS that either uses leapfrog (lfNUTS) or implicit midpoint
(iNUTS). Our code is freely available as an R package, and at the time of writing can be
obtained by emailing the authors.
6.4.1 2-D Gaussian
As discussed in Section 6.2.2, the leapfrog stability limit for a multivariate Gaussian
is directly related to the largest eigenvalue of the inverse covariance matrix. One of the
ways this eigenvalue can be large is when the multivariate Gaussian is highly correlated.
To illustrate how this affects NUTS in practice, we compared the average tree depth per
sample of lfNUTS and iNUTS for varying levels of ρ on the two-dimensional Gaussian
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Figure 6.6: For highly correlated Gaussian distributions, the leapfrog integrator in
lfNUTS is forced to take tiny stepsizes that result in larger average NUTS tree depths.
As the correlation goes to zero, the average tree depth approaches that of iNUTS.
distribution with mean zero, and covariance matrix
Σ =
1 ρ
ρ 1
 . (6.13)
The empirical scaling of average tree depth over 1,000 NUTS samples versus 1− ρ is
shown in Figure 6.6. In the NUTS algorithm, tree depth is selected automatically, when
a Hamiltonian trajectory has “U-turned”. Two to the power of the tree depth represents
how many steps in the trajectory were computed. For more correlated distributions,
leapfrog is forced to take smaller stepsizes, which results in more steps having to be
taken and thus larger tree depths. Note that for a Gaussian system, implicit midpoint
has no stepsize limit for stability regardless of the covariance of the Gaussian. Thus the
stepsize can be chosen large enough so that a tree depth of only one is required.
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6.4.2 Banana Distribution
To illustrate how the implicit midpoint integrator is advantageous for distributions
with nonlinear correlations that cannot be addressed by a mass matrix, we compared
lfNUTS and iNUTS on a highly-correlated banana distribution [80] with parameters
a = 1 and b = 100 whose probability density function (PDF) takes the following form:
p(q1, q2)
=
1
2pi
exp
{
−1
2
[
a2q21 +
q2 − ab(a2q21 + a2)
a2
]}
. (6.14)
The highly-nonlinear correlation structure of this distribution is typical for compli-
cated non-Gaussian distributions. For HMC, the long direction across the length of the
banana compared to its narrow width creates a prototypical multiscale problem, forcing
leapfrog to take an excessively small stepsize that leads to insufficient exploration of the
posterior in lfNUTS compared to iNUTS (Figure 6.7).
A summary of results comparing the two methods is presented in Table 1. Because
the implicit midpoint steps within iNUTS require a nonlinear solve, there is much more
overhead in each step compared to leapfrog. However, because implicit midpoint has
a much larger stability limit than leapfrog, iNUTS is able to take a much larger step,
leading to more efficient samples. In practice, iNUTS ends up needing to do only a third
of the work as lfNUTS to obtain an effective sample. In terms of computer time, iNUTS
took about 30% longer to obtain over ten times as many effective samples.
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Figure 6.7: 1,000 samples of the banana distribution from lfNUTS and iNUTS. Be-
cause of the multiscale nature of the Hamiltonian system that arises when sampling
the banana distribution, lfNUTS is forced to use an unreasonably small stepsize that
nearly reduces its behavior to that of a random walk and renders it unable to explore
the entire distribution (orange samples). Meanwhile, iNUTS can effectively take ten
times as large of a stepsize which allows it to efficiently explore the entire posterior.
lfNUTS iNUTS
avg. grad evals/step 2.00 11.98
avg. hess-vec evals/step 0.00 9.88
avg. work/step 2.00 21.86
avg. tree depth 9.97 5.40
avg. effective samples 42.47 613.26
work/effective sample 47.09 16.11
total computer time (s) 181 231
Table 6.1: A comparison of the computation involved in the sampling experiment.
Average gradient evaluations and Hessian-vector evaluations are per step of the in-
tegrator, and work is the sum of these. Average effective samples are over all 11
dimensions being sampled. While iNUTS requires more work per step, because it
is able to take a much larger step than leapfrog, it can obtain many more effective
samples in a similar time frame.
98
Implicit Hamiltonian Monte Carlo Chapter 6
6.5 Discussion
We have shown that distributions exhibiting multiple scales limit the stepsize of the
leapfrog integrator in HMC, and how this limitation can be effectively circumvented by
utilizing the implicit midpoint integrator together with Newton-Krylov iteration. Fur-
thermore, we offered a practical implementation of implicit midpoint that is applicable
to Bayesian posterior sampling problems, and provided practical guidelines for choosing
which integrator to use, as well as the stepsize to use in the integrator. As illustrated in
our examples, using implicit midpoint together with Newton-Krylov instead of leapfrog
can provide a practical and significant efficiency boost in the context of NUTS.
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Conclusion
We have described several novel models and computational methods for Bayesian hierar-
chical modeling of biomedical data. We described various contributions to computational
Bayesian modeling, along with the problems from our applied work that motivated these
contributions.
First we describe our hierarchical disease progression model, for modeling patient
disease trajectories. We then described the intricacies of the nonlinear trajectories in
the model and how we applied it to the progression of dementia in Alzheimer’s disease.
Next we described our work on the Givens Representation of orthogonal matrices to
infer models with orthogonal matrix parameters. We described the innovations in our
method along with our motivating hierarchical problem based on the analysis of protein
biomarkers of coagulopathic trauma patients. Next, we described a mechanistic model
of coagulopathy that relates clotting assay data to protein concentrations, effectively
providing a fast and convenient way for clinicians to understand key protein markers
involves in clotting.
Lastly we described our Implicit Hamiltonian Monte Carlo (HMC) method and il-
lustrated the connection between multiscale posterior distributions and the efficiency of
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HMC. We demonstrated the practical efficiency of our approach on several examples.
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Deriving the Change of Measure
Term in the Givens Representation
We start with the determinant of the matrix form of the change of measure term from
Expression 3.10 (reproduced below):

GT2:nJY1(Θ)(Θ)
GT3:nJY2(Θ)(Θ)
...
GTp:nJYp(Θ)(Θ)

(A.1)
For l = 1, · · · , n, let us define the following shorthand notation
∂i,i+lYk :=
∂
∂θi,i+l
Yk (A.2)
and
∂iYk :=
(
∂i,i+1Yk ∂i,i+2Yk · · · ∂inYk.
)
(A.3)
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In the new notation Equation can be written in the following block matrix form:

GT2:n∂1Y1 G
T
2:n∂2Y1 · · · GT2:n∂pY1
GT3:n∂1Y2 G
T
3:n∂2Y2 · · · GT3:n∂pY2
...
...
. . .
...
GTp:n∂1Yp G
T
p:n∂2Yp · · · GTp:n∂pYp

. (A.4)
First note that the block matrices above the diagonal are all zero. This can be seen by
noting that the rotations in the Givens representation involving elements greater than i
will not affect ei, i.e. letting Ri := Ri,i+1 · · ·Rin,
Yi = R1R2 · · ·Rpei = R1 · · ·Riei. (A.5)
Thus for j > i, ∂jYi = 0 and the determinant of Expression A.4 simplifies to the product
of the determinant of the matrices on the diagonal i.e. the following expression:
p∏
i=1
det
(
GTi+1:n∂iYi
)
. (A.6)
A.1 Simplifying Diagonal Block Terms
Let Ii denote the first i columns of the n × n identity matrix and let I−i represent
the last n− i columns. The term GTi+1:n in Expression A.6 can be written as
GTi+1:n = I
T
−iG
T = IT−iR
T
p · · ·RT1 . (A.7)
To simplify the diagonal block determinant terms in Expression A.6 we take advantage
of the following fact:
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det
(
GTi+1:n∂iYi
)
= det
(
IT−iR
T
p · · ·RT1
)
= det
(
IT−iR
T
i · · ·RT1 ∂iYi
)
. (A.8)
In other words, the terms RTp · · ·RTi+1 have no effect on the determinant. This can be
shown by first separating terms so that
det
(
GTi+1:n∂iYi
)
= det
 IT−i︸︷︷︸
(n−i)×n
RTp · · ·RT1 ∂iYi︸︷︷︸
n×(n−i)
 (A.9)
= det
(
IT−i
[
RTp · · ·RTi+1
] [
RTi · · ·RT1 ∂iYi
])
, (A.10)
and then noticing that Ri+1 · · ·Rp only effects the first i columns of the identity matrix,
so that
IT−i
[
RTp · · ·RTi+1
]
= (Ri+1 · · ·Rp I−i)T = (I−i)T . (A.11)
Thus, Expression A.6 is equivalent to
p∏
i=1
det
(
IT−iR
T
i · · ·RT1 ∂iYi
)
. (A.12)
Now consider the k, l element of the (n− i)× (n− i) block matrix IT−iRTi · · ·RT1 ∂iYi. This
can be written as
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eTi+kR
T
i · · ·RT1 ∂i,i+lYi = eTi+kRTi · · ·RT1 ∂i,i+l(R1 · · ·Riei)
= eTi+kR
T
i · · ·RT1R1 · · ·Ri−1(∂i,i+lRiei)
= eTi+kR
T
i (∂i,i+lRiei). (A.13)
Since eTi+kR
T
i Riei = 0, taking the derivatives of both sides and applying the product rule
yields
∂i,i+l(e
T
i+kR
T
i Riei) = ∂i,i+l0
⇒ (∂i,i+leTi+kRTi )Riei + eTi+kRTi (∂i,i+lRiei) = 0
⇒ eTi+kRTi (∂i,i+lRiei) = −(∂i,i+leTi+kRTi )Riei. (A.14)
Combining (A.14) with A.13, the expression for the k, l element of IT−iR
T
i · · ·RT1 ∂iYi
becomes −(∂i,i+leTi+kRTi )Riei.
However, note that
eTi+kR
T
i = e
T
i+kR
T
in · · ·RTi,i+1 = eTi+kRTi,i+k · · ·RTi,i+1, (A.15)
and that the partial derivative of this expression with respect to i, i + l is zero when
k > l. Thus it is apparent that IT−iR
T
i · · ·RT1 ∂iYi contains zeros above the diagonal and
that det
(
IT−iR
T
i · · ·RT1 ∂iYi
)
is simply the product of the diagonal elements of the matrix.
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A.2 Diagonal Elements of the Block Matrices
To obtain the diagonal terms of the block matrices we directly compute −∂i,i+leTi+kRTi
for l = k, Riei, and their inner-product. Defining Dij := ∂ijRij,
−∂i,i+kRiei+k = −∂i,i+k(Ri,i+1 · · ·Ri,i+kei+k) (A.16)
= −Ri,i+1 · · ·Ri,i+k−1Di,i+kei+k (A.17)
(A.18)
= Ri,i+1 · · ·Ri,i+k−1

0
...
0
cos θi,i+k
0
...
0
sin θi,i+k
0
...
0

(A.19)
106
Deriving the Change of Measure Term in the Givens Representation Chapter A
= Ri,i+1 · · ·Ri,i+k−2

0
...
0
cos θi,i+k−1 cos θi,i+k
0
...
0
sin θi,i+k−1 cos θi,i+k
sin θi,i+k
0
...
0

(A.20)
=

0
...
0
cos θi,i+1 cos θi,i+2 · · · cos θi,i+k−1 cos θi,i+k
sin θi,i+1 cos θi,i+2 · · · cos θi,i+k−1 cos θi,i+k
...
sin θi,i+k−1 cos θi,i+k
sin θi,i+k
0
...
0

(A.21)
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which is zero up to the ith spot and after the i+kth spot. Note that the rotation matrix
Ri applied to the standard basis vector ei can be written as follows:
Riei = Ri,i+1 · · ·Rinei (A.22)
(A.23)
=

0
...
0
cos θi,i+1 cos θi,i+2 · · · cos θi,n−1 cos θin
sin θi,i+1 cos θi,i+2 · · · cos θi,n−1 cos θin
...
sin θi,n−1 cos θin
sin θin

. (A.24)
Finally, directly computing the inner-product of −∂i,i+leTi+kRTi and Riei we obtain
−(∂i,i+leTi+kRTi )(Riei) = cos2 θi,i+1 cos2 θi,i+2 · · · cos2 θi,i+k cos θi,i+k+1 · · · cos θin
+ sin2 θi,i+1 cos
2 θi,i+2 · · · cos2 θi,i+k cos θi,i+k+1 · · · cos θin
+ sin2 θi,i+2 cos
2 θi,i+3 · · · cos2 θi,i+k cos θi,i+k+1 · · · cos θin
...
+ sin2 θi,i+k cos θi,i+k+1 · · · cos θin
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= cos2 θi,i+2 cos
2 θi,i+3 · · · cos2 θi,i+k cos θi,i+k+1 · · · cos θin
+ sin2 θi,i+2 cos
2 θi,i+3 · · · cos2 θi,i+k cos θi,i+k+1 · · · cos θin
...
+ sin2 θi,i+k cos θi,i+k+1 · · · cos θin
= · · ·
= cos θi,i+k+1 · · · cos θin
=
n∏
k=i+1
cos θik. (A.25)
Thus the determinant of the entire block matrix IT−iR
T
i · · ·RT1 ∂iYi simplifies to
n∏
k=i+1
(
n∏
j=k+1
cos θik
)
=
n∏
j=i+1
cosj−i−1 θij. (A.26)
Finally, combining this with Expression A.12 yields
p∏
i=1
det
(
IT−iR
T
i · · ·RT1 ∂iYi
)
=
p∏
i=1
n∏
j=i+1
cosj−i−1 θij. (A.27)
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Appendix B
Summary of Patient Demographics
and Missing Values for the
Application of the Givens
Representation
Injury Mech. N % Male Mean Age Std. Age % TBI Med. Blood Units
GSW 85 90 27 8 40 5.0
MVC 52 90 27 7 75 0.5
SW 21 71 29 8 14 3.0
Assault 16 100 27 7 94 0.0
Table B.1: Brief sub-cohort description including number of samples in each sub-co-
hort (N), percentage of the sub-cohort that is male, average and standard deviation of
age, percent of patients with traumatic brain injury, and median blood units recieved
in the sub-cohort.
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Summary of Patient Demographics and Missing Values for the Application of the Givens
Representation Chapter B
Table of Missing Values
Measurement Number of Missing Value (out of 174)
Proteins
FactorII 49
FactorX 50
Protein C 44
D-Dimer 54
Fibrinogen 123
Platelets 8
TEG
R 135
K 135
MA 133
Ly30 133
Table B.2: Number of missing values for each measurement type.
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Appendix C
Use of Cauchy Priors in Application
of the Givens Representation
We note that in the CCA model described in Chapter 4, we place Cauchy priors over the
scaling variables, Λ and Γ, which induce a sparsity property over latent dimensionality,
forcing Λ and Γ to go to zero unless the signal in the data is sufficiently strong. Similarly
we place Cauchy priors on the entries of the weight matrices W and B to induce sparsity
in the matrix entries for interpretability purposes. These Cauchy priors serve a purpose
that is akin to Laplace priors (or the L1 regularization in frequentist analysis), because
just like the Laplace prior, the Cauchy prior places most of its mass near zero, with
large mass in the tails of the distribution, allowing for appropriately large values when
statistical signal is strong enough. However, we prefer the Cauchy prior, as its continuity
property makes more sense in the context of our analysis (see [57] for a discussion on
using Cauchy priors over Laplace priors). Finally, we mention that the hyper-parameter
values of the Cauchy priors are chosen by leaving them as an unknown in our Stan model
and conducting full Bayesian inference to sample from their posterior distribution.
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Appendix D
Eigenvalues of the Update Matrix
for Implicit Midpoint on a Linear
System
For the simple univariate Gaussian system with mass matrix one defined in Section 6.2.2,
the update equations (6.9) reduce to
qn+1 = qn + h
(
pn + pn+1
2
)
(D.1)
pn+1 = pn − hσ2
(
qn + qn+1
2
)
.
In matrix notation, these update equations can be rewritten as
qn+1
pn+1
 =
 1 h2
−h
2
σ2 1

qn
pn
+
 0 h2
−h
2
σ2 0

qn+1
pn+1
 . (D.2)
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Collecting the n+ 1 terms on the right yields
 1 −h2
h
2
σ2 1

qn+1
pn+1
 =
 1 h2
−h
2
σ2 1

qn
pn
 , (D.3)
which yields the update equation
qn+1
pn+1
 =
 1 −h2
h
2
σ2 1

−1 1 h2
−h
2
σ2 1

qn
pn

=
1
1 + h
2
4
σ2
 1 h2
−h
2
σ2 1

 1 h2
−h
2
σ2 1

qn
pn

=
1
1 + h
2
4
σ2
1− h24 σ2 h
−hσ2 1− h2
4
σ2

qn
pn
 . (D.4)
Note that the eigenvalues of the scalar times the matrix in this equation are simply
the eigenvalues of the matrix times the scalar in front. Defining µ := (h2/4)σ2 these
eigenvalues are the solutions of the quadratic equation
λ2 − 2(1− µ) + (1− µ)2 + h2σ2 = 0 (D.5)
which by the quadratic formula are
λ1,2 = (1− µ)± hσi. (D.6)
Thus the moduli of the eigenvalues of the overall update matrix are one.
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